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Abstract 
Adolescence is a period in which many are first introduced to cigarettes. With 
adolescence being a plastic neurodevelopmental period, exposure to addictive substances, 
like nicotine, may lead to abnormal neural development and consequently, behavioural and 
cognitive deficits. Importantly, nicotine exposure is linked to various psychiatric conditions 
including anxiety and depression. To assess the long-term neuropsychiatric-like effects of 
adolescent nicotine exposure, adolescent (PND 35-44) and early adult (PND 65-74) rats were 
exposed to nicotine. Once adults (PND 75), or later in adulthood (PND 105), rats were 
analyzed with a battery of behavioural, cognitive, molecular and cellular assays. Following 
adolescent, but not adult nicotine exposure, rats developed depressive and anxiety disorder 
phenotypes including temporal memory and social motivation deficits, relative to controls. 
Adolescent behavioural results were associated with a hyperdopaminergic, sub-cortical state 
at the level of the mesolimbic pathway and an upregulation in pERK1/2 and downregulation 
in D1DR expression levels in the PFC.  
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1 Introduction 
 
Smoking is one of the leading causes of preventable death in North America, 
(WHO, 2017) and is known to have a high co-morbidity with various neuropsychiatric 
disorders, including schizophrenia and mood disorders, such as major depression and 
anxiety (Schizophrenia Working Group of the Psychiatric Genomics Consortium, 2014; 
Boden, Fergusson & Horwood, 2010). Although smoking rates in North American have 
decreased substantially with the emergence of research exposing the carcinogenic effects 
of smoking, smoking has again regained popularity in more recent years with the 
increased use of electronic cigarettes, which have been purported to be safer than 
traditional rolled cigarettes (Callahan-Lyon, 2014). The driving force behind the 
addictive nature of smoking both traditional and electronic cigarettes, is due to the effects 
of its main psychoactive component, nicotine. Like many other drugs of abuse, nicotine 
exerts its effects primarily on the mesocorticolimbic dopaminergic (DAergic) system. 
Nicotine’s effects on the DAergic system have been previously described through lesion 
studies by Corrigal and colleagues in 1992, which showed that lesions of the DA system 
were responsible for the reinforcing effects of nicotine, in rats that were chronically 
exposed. In this study, Corrigal and colleagues (1992), lesioned the dopaminergic 
efferents into the accumbens. Following these lesions, animals reduced the amount of 
self-administration of nicotine. In contrast, blockade of mesocorticolimbic DA signaling 
has been shown to dramatically potentiate the rewarding effects of nicotine in the drug-
naïve state (Laviolette and van der Kooy, 2003). However, following chronic nicotine 
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exposure and dependence, DA signaling is required for the addictive properties of 
nicotine in the mesocorticolimbic system (Tan et al., 2009).  
Adolescence is a period in which many people are first introduced to cigarettes. 
This is also a critical period of neurodevelopment, particularly in frontal cortical brain 
regions. During adolescence, the frontal cortex is still developing by way of ongoing 
myelination as well as synaptic pruning events (Knuesel et al., 2014). Based on the 
plastic nature of the brain during this period of development there is the potential for 
abnormal neurodevelopment and changes to mesocorticolimbic networks as a result of 
exposure to drugs of abuse, like nicotine. Previous research has described a host of 
cognitive, emotional and behavioural deficits that progress into adulthood following 
chronic exposure to nicotine during adolescence (Holliday & Gould, 2016; Counotte et 
al, 2009). Counotte and colleagues, for example, described cognitive deficits in the 5 
choice serial reaction time task (5-CSRTT; 2009). Previous work has also described 
conflicting long-term behavioural effects of adolescent nicotine. With studies describing 
varying levels of anxiety and cognitive deficits, with some citing no deficits. Most 
evidence supports an increase in anxiety-like behaviours and increased reward sensitivity 
(Holliday & Gould, 2016).  Nevertheless, little work has been done to understand the 
molecular and cellular changes that might underlie these deficits following adolescent 
nicotine exposure. Several previous studies have noted molecular alterations in various 
neural regions following neurodevelopmental nicotine exposure. For example, Trauth and 
colleagues (1999) noted an upregulation in nAChRs in the cortex and hippocampus of 
rats that were chronically exposed to nicotine 4 weeks after treatment. The same group 
also described a decrease in cholinergic activity following adolescent nicotine exposure 
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(Trauth et al., 2000). Counotte and colleagues (2009), along with working memory 
deficits in a 5-choice serial recognition task, also described an increase in DA levels in 
the prefrontal cortex (PFC) when analyzing the tissue of adult rats that were chronically 
exposed to nicotine during adolescence. This suggests that neurodevelopmental nicotine 
exposure may be associated with persistent plastic alterations in mesocorticolimbic DA 
activity states. 
In an interesting study by Boden and colleagues (2010), a causal link was reported 
between nicotine dependence and the development of depressive symptoms. In these 
experiments, a longitudinal approach was taken to assess the level of dependence on 
nicotine and the resulting depressive symptoms over time. The groups’ results best fit a 
causal model in which nicotine dependence directly resulted in increased risk of 
depression, as opposed to a model in which both stemmed from a common external factor 
(Boden et al., 2010). Furthermore, a review article by Jane-Llopis and Matytsina (2006), 
describes the many epidemiological studies that have linked smoking to depression and 
anxiety disorders in various westernized regions around the world.  In this review, 
nicotine was found to be related to psychiatric disease in a dose-response relationship 
(Jane-Llopis & Matysina, 2006). 
Nevertheless, despite a large body of clinical literature identifying correlative 
links between smoking behavior and the development of mood disorders like anxiety and 
depression, there is virtually nothing known about the underlying, causal brain 
mechanisms that may be responsible for these co-morbidities. The primary aim of my 
research project was to use a multi-pronged pre-clinical neuroscience research approach 
aimed at identifying and characterizing how adolescent neurodevelopmental nicotine 
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exposure might lead to persistent alterations in neuronal and molecular states in the 
mesocorticolimbic DA system. Furthermore, my research project aimed to characterize 
how these neurodevelopmental alterations might lead to persistent symptoms of 
depressive and anxiety-like disorders in later adulthood, as they have been demonstrated 
in the above discussed epidemiological studies.  
 
1.1 Prevalence of Smoking in North America 
Smoking has been a practice in many religious ceremonies for thousands of years in 
ancient Egypt and Greece and in North America; tobacco has been growing for almost 
8000 years in the wild (Cancer Council NSW, 2011). Smoking has, over the years, 
moved from a cultural/religious practice to a common practice with the development of 
cigarettes and increased promotional content. With increasing evidence of tobacco’s 
addictive and carcinogenic effects, the world health organization (2017), along with 
governing bodies, started to initiate mechanisms of tobacco control through public 
awareness campaigns. Over time, increasing public awareness of the dangers of tobacco 
exposure has led to a significant reduction in smoking behaviours, particularly in North 
America (WHO, 2017). Nevertheless, smoking remains the leading cause of preventable 
death worldwide.  
In Canada, cigarettes as well as electronic cigarettes containing nicotine, are not 
approved for sale, importation or advertising to minors, under the Food and Drugs Act 
(Hamilton et. al, 2015). Canadian trends in both cigarette and e-cigarette use follow the 
same trends that are noted in the US. In both countries, there is a steady increase in high 
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school students that have tried some form of cigarettes in their life (Hamilton et. al, 2015; 
Schepis & Rao, 2005). In an Ontario study of drug use in 2015, almost 15% of students 
had used an e-cigarette and 24% of students had reported smoking tobacco cigarettes in 
their lifetime, with males from Caucasian backgrounds having greater odds of using e-
cigarettes as opposed to females and non-white racial backgrounds (Hamilton et. al, 
2015). All across Canada we are seeing trends of increased awareness and use of 
cigarettes among adolescents. In a Canada wide study from 2014, Czoli and colleagues 
found that close to half of 1188 youth and young adults had been exposed to e-cigarettes 
and just over 16% had reported trying them (Czoli et. al, 2014). E-cigarettes are a 
relatively new phenomenon, and still not as popular as traditional cigarettes, but both still 
contain nicotine, which is the compound of interest for this thesis, and one that has been 
previously associated with various neuropsychiatric disorders (Boden et al., 2010; Jane-
Llopis & Matysina, 2006). 
 
1.2 Adolescent Neurodevelopment 
Adolescence is a period characterized by many behavioural and physical changes as a 
result of puberty. Puberty is usually characterized by the physical changes that take place 
as adolescents reach sexual maturity.  Even though the trigger that represents the onset of 
puberty is not well understood, that trigger results in hormonal changes through the 
hypothalamic-pituitary axis that then cascades into physical changes and growth (HPA 
axis; Sisk & Foster, 2004). On average, in developed countries, puberty begins at the age 
of 13 for females and 15 for males, with differences found among varying countries and 
ethnicities within those countries (Parent et al., 2003). Adolescent brain development is 
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accompanied by a wide variety of behavioural and emotional changes and considerable 
research has examined changes in emotional processes as well as risk taking behaviours 
associated with these neurodevelopmental changes (Smith, Chein & Steinberg, 2014; 
Steinberg, 2008; Romer, 2009). The increase in risk-taking behaviours can ultimately 
lead to increases in inappropriate behaviours such as, smoking, drinking alcohol and risky 
sexual behaviour, to name a few.  
Many of the critical neurodevelopmental changes during adolescence occur in higher 
cortical areas like the PFC, through the processes of myelination and synaptic pruning 
(Spear, 2013). During the adolescent period there is not only the expansion and 
regression of cortical areas, but reorganization of other areas, like reward processing 
mechanisms in the striatum and associated areas, such as the VTA and NAcc (Spear, 
2013).  In the mesocorticolimbic dopaminergic pathway there can be a 2 to 7-fold 
increase in dopaminergic activity (Spear, 2013). This increase in DA activity and 
decrease in associated DA receptors, could be the reason for changes in reward 
processing when a reward is anticipated, as well as explain the peak and following 
decrease in reward seeking behaviours in adolescence into adulthood (Spear, 2013). 
There is also evidence for a later development of neural responses to negative feedback 
as compared to positive feedback, leading to an insensitivity to negative stimuli during 
adolescence (Spear, 2013). This late opportunity for plasticity also gives way to sex-
hormone dependent changes (Sisk & Foster, 2004). These changes alter social behaviour 
with respect to mate seeking and copulatory behaviours (Sisk & Foster, 2004). Thus, both 
hormone driven behaviours as well as neurodevelopmental changes could ultimately 
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result in a propensity to engage in smoking behaviours linked to a desire for social 
acceptance concomitant with the reinforcing effects of nicotine.  
 
1.3 Affective Disorders 
Affective disorders are among the most prominent types of psychiatric disorders in 
westernized society (Schulz & Arora, 2015; McCarron, Vanderlip and Rado, 2016). 
Affective disorders include, but are not limited to, bipolar disorders I and II, depressive 
disorders and anxiety disorders. For the purposes of this paper, depressive and anxiety 
disorders will be the focus based on their high rates of co-morbidity as well as their 
strong links to substance abuse problems (Schulz & Arora, 2015; McCarron et al., 2016; 
Stein & Sareen, 2015).  
Depression is associated with huge economic costs and has been increasing in 
frequency with prevalence rates as high as 40% in certain populations (McCarron et. al, 
2016). Many people will experience at least one depressive episode in their life, with 
certain populations, namely female, single individuals and those from low socioeconomic 
status (SES), being more susceptible to depression (Schulz & Arora, 2015). Depression is 
one of the most common psychiatric disorders both as a comorbid diagnosis or on its own 
(Schulz & Arora, 2015). It is a common presenting symptom in psychiatric disorders 
such as major depressive disorder (MDD), bipolar disorders, schizophrenia as well as in 
some neurodegenerative diseases (Schulz & Arora, 2015). Depression co-occurs 
frequently with anxiety disorders, substance abuse problems, impulse control disorders, 
anorexia nervosa and bulimia nervosa (Schulz & Arora, 2015). While specific causes of 
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depression are unknown, there have been associations with genetic factors as well as 
neuroanatomical variations such as decreased brain volume in the PFC, orbitofrontal 
cortex, cingulate cortex, hippocampus and striatum (Schulz & Arora, 2015). The 
diagnosis of depression requires patients to express 5 or more of the DSM-5 symptoms 
over the period of two weeks, with one symptom including a depressed mood or 
anhedonia (McCarron et. al, 2016). Other symptoms include disruptions in sleep, 
appetite, fatigue, large changes in weight, feelings of worthlessness, suicidal thoughts. 
Depression causes clinically significant distress or impairments in social, occupational or 
other areas of functioning (McCarron et. al, 2016). Depression can vary in severity with 
different treatment plans for the varying levels. Mild cases of depression can sometimes 
be treated with exercise and might not require medications, mild to moderate depression 
responds well to medication or psychotherapy and severe major depressive disorder 
patients benefit from medication or a combination of medication and psychotherapy 
(McCarron et. al, 2016). It is important to note that medications do not always work for 
every patient and there’s a large variety in the mechanism of actions for the different 
generations of currently prescribed antidepressants (McCarron et. al, 2016).  
Anxiety disorders can be classified as a generalized anxiety disorder (GAD) or may 
be associated with a more specific cause of anxiety. More specific anxiety disorders 
include a variety of well-known psychiatric disorders such as obsessive compulsive 
disorder, social anxiety, panic disorders and post-traumatic stress disorder, to name the 
most common (Stein & Sareen, 2015).  
The data describing the global prevalence of anxiety disorders is variable based on its 
co-morbidities and the overlap symptoms have with other psychiatric disorders such as 
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depression (Baxter et. al, 2013). A regressional analysis of data and trends worldwide 
estimates global prevalence at 7.3% of the population having ever suffered from GAD 
and 10.4% in European/Anglophone cultures (Baxter et. al, 2013). Risk factors and 
factors found to be responsible for the variability in the global data include age, gender, 
culture, conflict, SES and urbanity, with being female, coming from low SES, childhood 
adversity, abuse and substance abuse being risk factors (Baxter et. al, 2013; Stein & 
Sareen, 2015). To diagnosis GAD, a patient must have excessive anxiety and worry about 
various events that have persisted for 6 months with episodes or worry more days than 
not over that period of time (Stein & Sareen, 2015). The patient must find it difficult to 
control the worry and meet 3/6 of the symptoms listed in the DSM-5. Symptoms include 
disturbances in sleep, concentration, feelings of restlessness and muscle tension (Stein & 
Sareen, 2015). As mentioned, GAD is often a coexisting condition with depression, 
which has overlap in diagnoses symptomology (Stein & Sareen, 2015). Functional 
neuroimaging studies have demonstrated an increase in activation in the limbic system, 
decrease in activation in the PFC and diminished functional connectivity between these 
two regions (Stein & Sareen, 2015). Treatment for GAD is similar to that of MDD with a 
mix of pharmacotherapy (usually targeting the serotinergic system with drugs that are 
commonly used in treating depression) and psychotherapy (such as cognitive behaviour 
therapy (CBT), also used in depression) being the common choices for physicians (Stein 
& Sareen, 2015).  
While the incidences of both of these disorders described are consistently increasing 
in the population, more research needs to be done with respect to the causes and 
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development of the two disorders to prevent further increases as well as better understand 
the etiology of them. 
 
1.4 Physiological and Neurobiological Effects of Smoking 
Beyond the well described effects of smoking on the body, such as the carcinogenic 
effects on lungs, throat and mouth, there are effects taking place on the brain through 
nicotine, the psychoactive compound found in cigarettes, that ultimately lead to the 
addictive quality of smoking. There are well-established acute and long-term effects of 
nicotine on the brain.  
First time smokers will often describe feelings of nausea, coughing and dizziness, that 
then begin to subside with repeated nicotine exposure, as a tolerance to the negative 
effects develops (Laviolette & Van Der Kooy, 2004).  First time smokers also have larger 
increases in heart rate, systolic and diastolic blood pressures as well as larger increases in 
plasma nicotine levels as compared to long-term smokers, with individual differences in 
sensitivity to nicotine (Pomerleau, 1995). This idea of individual differences with respect 
to sensitivity to nicotine is thought to play a role in the development of an addiction to 
nicotine, with those who are less sensitive developing an addiction (Pomerleau, 1995). 
The individual differences in sensitivity are thought to be related to genetics as well as 
differences in nicotinic receptor expression levels (Pomerleau, 1995).  
Like many other drugs of abuse, nicotine acts on the mesocorticolimbic DA system, 
including the ventral tegmental area (VTA), a midbrain region containing the A10 DA 
neurons, which is involved in many functions including; learning, memory and reward 
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processing (Laviolette & Van Der Kooy, 2004). The VTA is predominately made up of 
DA neurons with a subpopulation of GABAergic interneurons (Swanson, 1982). The 
acute effects of nicotine are predominantly through nicotinic acetylcholine receptors 
(nAChRs) on the GABAergic neurons in the VTA (Laviolette & Van Der Kooy, 2004). 
Though these receptors desensitize rapidly, leading to a long lasting excitatory effect on 
the DA neurons by way of disinhibition from the now inactive GABA neurons 
(Laviolette & Van Der Kooy, 2004). This acute reward circuitry also involves the input 
of the pedunculopontine tegmental nucleus (PPT) on the VTA to produce the rewarding 
effects of nicotine ( Laviolette et al., 2002). It is important to note that nAChRs are 
present throughout the body, in muscle, skin and organ cells, with different subunit 
conformations, each able to bind nicotine with varying affinities (Albuquerque et. al, 
2009). The initial effects on the GABAergic neurons, and then subsequent sensitization to 
nicotine, through the DAergic neurons, relates to the initial aversive effects of nicotine 
that then gives way to the rewarding effects. 
 Nicotine, unlike other drugs of abuse, isn’t immediately addictive, but produces a 
gradual state of dependence associated with a variety of neuroplastic adaptations, while 
other drugs such as opiates, are more acutely addictive (Laviolette & Van Der Kooy, 
2004). Research suggests that nicotine addiction isn’t initially dependent on DA 
transmission through the mesocorticolimbic pathway, but through the efferents of the 
PPT on the VTA (Laviolette et. al, 2002, Laviolette & Van Der Kooy, 2004, Tan et. al, 
2009). Long term, smoking functionally changes transmission of DA through the 
mesocorticolimbic pathway, increasing DA release through the pathway (Tan et. al, 2009, 
Laviolette & Van Der Kooy, 2004). Initially described by Robinson & Berridge in 1993, 
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then applied to nicotine addiction by Laviolette & Van Der Kooy in 2004, the Incentive 
Salience of nicotine induces sensitization of DA pathways. This theory suggests that 
nicotine induces a sensitization of the DA pathway that coincides with an increase in 
salience of the drug (Laviolette & Van Der Kooy, 2004, Robinson & Berridge, 1993).  
 
Figure 1. The acute and long term reward pathways. Figure adapted from Laviolette and Van Der Kooy 
(2004).   
 
1.5 The Roles of DA D1 vs. D2 Receptors in the PFC 
The dopaminergic system, as described in the previous section, has been implicated in 
the rewarding properties of nicotine addiction. Not only is the PFC an important structure 
in the mesolimbic pathway, but it has also been implicated with morphological 
differences in patients suffering from depression and anxiety disorders (Schulz & Arora, 
2015). This makes the receptors for that mesolimbic dopaminergic pathway, specifically 
within the PFC, of great interest for the purposes of this thesis. 
PPT
NAcc 
PFC 
VTA 
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Dopamine is a neurotransmitter that is implicated in a whole host of activities, from 
movement to learning and memory to reward processing, acting on a variety of receptors, 
throughout the brain. The two important, and very different classes of DA receptors are 
the D1 and D2 receptors. Interestingly, these two receptors have opposing actions, with 
the D1 receptor activating adenylyl cyclase and cascading pathways, while the D2 
receptor inhibits the action of the adenylyl cyclase cascade (Trantham-Davidson, Neely, 
Lavin & Seamans, 2004). Activation of the D1 receptor results in increases in fast-
spiking interneuron excitability and presynaptic modulation in the PFC (Trantham-
Davidson et al., 2004). Conversely, activation of the D2 receptor results in reduced 
interneuron excitability (Trantham – Davidson et al., 2004).  
Functionally, D1 receptors in the PFC, have been implicated in working memory and 
executive function while D2 stimulation has been demonstrated to not affect these two 
functions (Floresco, 2013). Results of patch-clamp experiments have described opposing 
effects of these two receptor subtypes, and different downstream molecular pathways in 
which they exert their neuronal effects (Trantham-Davidson et al., 2004). D1 receptors 
have been implicated upstream in the de-phosphorylation of ERK, moving ERK from the 
phosphorylated, active, state to the dephosphorylated, inactive, state (Girault et al., 2007; 
Beaulieu, Espinoza & Gainetdinov, 2014). Both D1 and D2 receptors have an effect on 
the function of CaMKII through IP3 activity and therefore the movement of calcium 
within the cell, with the D2 receptor having a stronger relationship with CaMKII 
functioning (Beaulieu et al., 2014, Rosen et al., 2016). Previous work looking at opiate-
induced adaptations to the D1/D2 signaling system, describe a D2-CaMKII-dependent 
signaling in the acquisition of opiate reward memories in drug naïve states, that 
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functionally reverses following chronic exposure (Rosen et al., 2016). Previously, the 
group had found similar results with D1-ERK-dependent signaling and a functional 
reversal in the BLA of opiate naïve and chronic exposure states respectively (Lyons et al., 
2013). This research describes the importance of both the DA system and its downstream 
effector molecules in the processing of rewarding stimuli, the formation of memories 
associated with addictive stimuli and the changes that occur following chronic exposure 
to addictive substances. 
 
1.6 The Functional Roles of ERK and CaMKII in Neuropsychiatric Disorders 
As described in the previous section, ERK and CaMKII are activated upstream by D1 
and D2 receptors respectively. CaMKII is directly activated by calmodulin with two 
bound calcium ions, as a result of calcium influx from calcium stores or extracellular 
sources (Shifman et al., 2006). CaMKII has been implicated in long term potentiation 
processes and, therefore, is critical to memory formation, as presented in the previous 
section with experiments by Rosen and colleagues (2016; Shifman et al., 2006). 
Furthermore, the beta isoform of CaMKII have been demonstrated to be up-regulated in 
the lateral habenula of animal models of depression, and furthermore, were found to be 
downregulated with the treatment of antidepressants (Li et al., 2013). ERK1/2 are 
activated when the Thr and Tyr residues are phosphorylated by MEK1/2 (Girault et al., 
2007). Drugs of abuse (addictive substances) have previously been shown to activate 
ERK1/2 in stereotypic places such as the NAcc, striatum, central amygdala as well as 
deep layers of the PFC (Girault et al., 2007). Interestingly, ERK1/2 seems to be important 
in reconsolidation of information during various learning paradigms in animal models 
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(Girault et al., 2007). Disruptions to the ERK1/2 pathway during ‘reconsolidation’ phases 
of experiments, eliminates the conditioned response to drugs (Girault et al., 2007). 
Furthermore, ERK1/2 has been implicated in cell growth and differentiation as well as 
neuronal plasticity (Girault et al., 2007). Both molecules have been implicated in both 
affective disorders as well as substance abuse and are therefore important targets in 
understanding how long term nicotine addiction relates to depression and anxiety 
disorders.  
 
1.7 Epidemiology of Adolescent Smoking and Mood Disorders 
Previous studies of epidemiology and etiology of nicotine use among adolescence 
have explored the prevalence of smoking and how it may correlate with other 
psychosocial stressors, socioeconomic status, comorbid addictions, and the development 
of neuropsychiatric illnesses. Some risk factors that have been associated with greater 
risk of nicotine dependence, along with other drugs of abuse, is impulsivity, inattention, 
novelty seeking and disinhibition (Perkins et. al 2008). Childhood abuse, low 
socioeconomic status as well as nonspecific stress have all been described as significant 
risk factors for adolescent smoking (Schepis & Rao, 2005). Furthermore, parental and 
peer smoking within a social group has been consistently associated with increased risk 
in smoking (Schepis & Rao, 2005).  
Smoking has previously been described to be strongly correlated with depression 
(Boden, Fergusson and Horwood, 2010; Schepis & Rao, 2005; Jané-Llopis & Matytsina, 
2006). An interesting, and uncommon longitudinal study of adolescents in New Zealand, 
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describes a causal relationship between smoking and depressive symptoms (Boden et. al, 
2010). In this study participants were questioned at ages 18, 21 and 25 and measured for 
frequency of smoking and a self-report questionnaire examining DSM-IV criteria for 
nicotine dependence as well as interviewed on a structured mental health interview used 
to assess aspects of mental health and psychosocial adjustment (Boden et. al, 2010). The 
study ultimately reported a significant comorbidity between major depression and 
nicotine dependence. The relationship couldn’t be described by a common source and 
was causal with nicotine leading to depression (Boden et. al, 2010). Along with the well-
established depressive association, nicotine has been linked to a number of psychiatric 
disorders including anxiety disorders, somatoform disorders and schizophrenia (Jané-
Llopis & Matytsina, 2006). Furthermore, smoking has also been associated with deficits 
in cognitive function with respect to working memory, attention and executive planning 
(Chamberlain et. al, 2012). Much of the epidemiological evidence relating smoking with 
psychiatric diagnoses is conflicting as to the nature of their relationship. Further research 
needs to be conducted to better describe these relationships.  
 
1.8 Preclinical Studies of Adolescent Nicotine Exposure 
Preclinical studies refer to the use of animal models to better understand the 
mechanism of action of a drug or disorder before moving to clinical studies and trials 
using humans. The use of animal models in long term studies is also preferable for the 
speed in which researchers are able to see long term effects of a drug. A rat, for example, 
has a much shorter life cycle as compared to humans, have similar neural structures 
responsible for motivation, reward and learning as well as social structures, making them 
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ideal experimental subjects to investigate neural substance abuse mechanisms. Preclinical 
studies are important for understanding both acute and lasting effects of nicotine, 
especially during the critical period of neurodevelopment taking place in adolescence. 
The acute effects of nicotine were described in section 1.4 of this introduction 
“Physiological and Neurological Effects of Smoking”, therefore the preclinical analyses 
of long lasting effects of adolescent nicotine use will be further described in this section. 
Previous preclinical work has suggested that exposure to nicotine during 
periadolescence increases the sensitivity to addictive properties of nicotine during 
adulthood, as described in a bar press self-administration experiment (Goriounova & 
Mansvelder, 2012). Other experiments have described changes in grooming, locomotor 
and rearing activity during and following adolescent nicotine treatment (Trauth, Seidler 
& Slotkin, 2000). Further behavioural changes such as anxiogenic and changes in fear 
behaviour have also been reported (Dwyer, McQuown & Leslie, 2009). The most heavily 
reported long term effect is the anxiogenic effects of chronic adolescent nicotine 
exposure (Dwyer, McQuown & Leslie, 2009; Goriounova & Mansvelder, 2012; Slaweki, 
Thorsell, Khoury, Mathe & Ehlers, 2005; Slawecki, Gilder, Roth & Ehlers, 2003). Short 
term, nicotine can have a pro-cognitive effect, while long term nicotine has been shown 
to have negative cognitive effects as demonstrated through visuospatial attentional tasks 
and serial recognition tasks (Dwyer, McQuown & Leslie, 2009; Counette et al., 2009). 
Furthermore, in these tasks there was an increase in premature responses in adolescent 
nicotine treated rats, suggesting an increase in impulsivity among those exposed to 
nicotine during adolescence (Dwyer, McQuown & Leslie, 2009; Counette et al., 2009).  
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There have been fewer studies examining the cellular and molecular changes 
following chronic adolescent nicotine exposure. One such study describes an increase in 
DA release at the boutons in the PFC followed electrical stimulation of the axons of the 
DA neurons innervating the PFC (Counette et. al, 2009). Other articles have described 
changes in DA transmission through an upregulation of transporter densities and 
increased DA content in the striatum (Dwyer, McQuown & Leslie, 2009). Further 
changes in nAChRs and serotonergic signaling have been described (Dwyer, McQuown 
& Leslie, 2009). The changes described in the cholinergic activity may impact a variety 
of neurotransmitter systems that are modulated by ACh (Dwyer, McQuown & Leslie, 
2009).  
The preclinical studies described each look at an aspect of adolescent nicotine use and 
have varying methodologies used within each set of experiments. This could lead to some 
of the varying results that are present in the literature. Further research should be done 
using a specific dose and exposure procedure to better understand the effects of 
adolescent nicotine exposure in terms of cellular and molecular changes and the resulting 
behavioural deficits.   
 
1.9 Research Objectives and Hypothesis  
From this brief review of the literature concerning the links between adolescent 
neurodevelopment, smoking behaviours and mood disorders, it is clear that there are 
many unanswered questions concerning how and why adolescent smoking may 
contribute to complex mood disorders like MDD or anxiety. The primary research 
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objective of my thesis was to characterize and identify the effects of adolescent, 
neurodevelopmental exposure to nicotine on the developing mesocorticolimbic DA 
system, focusing on the VTA and PFC regions. Pursuant to this, my objective was to 
examine how these alterations may subsequently lead to neuronal, molecular and 
behavioural symptoms of mood disorders, using pre-clinical behavioural pharmacological 
modelling in rats.  
Given the previously described research implicating the role of the PFC and 
mesocorticolimbic DA system in the effects of both nicotine addiction and mood 
disorders, my overarching hypothesis is that adolescent neurodevelopmental exposure 
to chronic nicotine will cause long-term and persistent neuropathological alterations in 
the mesocorticolimbic DA system associated with symptoms of depression and anxiety 
and associated neuronal and molecular adaptations in the PFC-VTA circuitry. I have 
addressed this research hypothesis with the following specific AIMS: 
AIM 1: Characterize the effects of adolescent neurodevelopmental nicotine exposure 
on later adulthood measures of affective processing, anxiety, cognitive and depressive-
like symptoms. 
AIM 2: Characterize the molecular effects of adolescent neurodevelopmental 
nicotine exposure on later adulthood measures of DA D1, D2 and their downstream 
signaling pathways, ERK 1/2 and CaMKII directly in the PFC. 
AIM 3: Characterize the effects of adolescent neurodevelopmental nicotine exposure 
on later adulthood measures of baseline changes in the neuronal activity states of VTA 
DA neurons. 
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2 Methods 
 
2.1 Animal Models 
Groups of adolescent and adult male Sprague-Dawley rats were obtained from 
Charles River (Quebec, Canada) at postnatal days (PND) 30 and PND 60, respectively. 
Rats were housed in pairs in a temperature controlled 12-hour light-dark cycle facility. 
Housing consisted of a plexi-glass box with a corn bedding base and environmentally 
enriched with paper towel, paper nesting material as well as a wooden block to chew. 
Rats were left to habituate to the facility and housing for four days prior to being handled. 
Food and water were available ad libitum for the duration of the experiments except 
when otherwise specified. The two days leading up to their pre-treatment, rats were 
handled and habituated to the procedure of injections (without needle/syringe). Rats were 
then pretreated with subcutaneous injections of 0.4 mg/kg of nicotine (-/- nicotine 
bitartrate, Sigma-Aldrich Chemicals; s.c.) or a phosphate buffered saline vehicle solution. 
Injections were done three times a day (10:00/13:00/15:00) for 10 consecutive days (PND 
35-44 or PND 65-74; Figure 2) as previously described by Counette and colleagues 
(2004). Following the pre-treatment, rats were left to develop with no other interventions 
until PND 75 or 105 for the adolescent and adult groups respectively (Figure 2). All 
experiments followed approved government and institutional standards of care.  
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 Figure 2. Timeline of Pretreatment. Animals arrived at PND 30/60 for the adolescent/adult cohorts to 
allow animals to habituate to their new housing/facility. From PND 35-44/65-74 the adolescent/adult 
cohorts received 0.4 mg/kg of nicotine three times per day. At PND 75/105 animals began the testing as 
described in section 2.  
 
2.2 Behavioural and Cognitive Testing 
Once PND 75, for the adolescent cohort, or PND 105, for the adult cohort, were 
reached, a battery of behavioural and cognitive assays were conducted to examine the 
long term effects of nicotine exposure. It is important to note that a minimum of 3 days 
were left between each experiment and experiments were ordered from least to most 
stressful to attempt to minimize any confounding variables. Furthermore, after each rat 
testing, chambers, cages, and all other testing objects and tools were cleaned with 50% 
ethanol to avoid olfactory cue biases. In all behavioural and cognitive tests there is an n 
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value of 10 animals per group (control and nicotine) with the exception of social 
interaction testing for the adolescent cohort, in which there is an n value of 20.  
 
2.21       Behavioural Tests  
The cognitive tests are as follows:  
 
Light Dark Box Test – The light dark box is an apparatus used as an unconditioned test 
of anxiety. The apparatus consists of two (50 x 25 x 37 cm) plexi-glass compartments 
divided in two by a wall that has a door (10 x 10 cm) on the bottom center of the wall. 
One side of the box has opaque black walls and a lid to create a fully dark space, the 
other side consists of opaque white walls and an open top, which a light is placed over to 
create a light open side with a 1500 lux at floor level (Figure 3a). The premise of this test 
is that one side is an aversive environment – the light side, and one is a non-aversive 
environment – the dark side. The level of anxiety in the animal is measured based on the 
spontaneous novelty-induced exploratory behaviour of the brightly illuminated and open 
areas as rodents have an innate aversion to those spaces (Kulesskaya & Voikar, 2014). In 
these experiments rats were habituated to the room in which the testing took place for 60 
minutes prior to testing. Testing consisted of 8 minutes of exploration. Rats were placed 
in the middle of the light side of the box with their head facing away from the door 
separating the two sides. Measures taken include the latency taken for the rat to enter the 
dark side from the beginning of the test in the light side (Latency 1), the latency for them 
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to return back from the dark side into the light side after entering the dark side for the 
first time (Latency 2), the total transitions between the sides and the time spent in each 
side.  
 
Social-Interaction Testing – Social interaction, as previously described by Renard et al., 
(2016), analyzes two aspects of social behaviour. This task evaluates social 
affiliation/motivation and social recognition memory in phases 1 and 2 respectively. The 
apparatus consists of 3 chambers, the center being an open space used for habituation to 
the apparatus, with two identical interaction chambers on either side separated by plexi-
glass walls with removable doors. In the center of each interaction chamber were 
individual metal cages for naïve rats to be explored by the rats in the experiments. Walls 
of all chambers are clear plexi-glass with removable doors between the center habituation 
area and two interaction chambers (Figure 3d). Rats were habituated to the test arena for 
13 minutes, 24 hours before testing and then day of, rats were habituated to the room, in 
which the testing took place, for 30 minutes prior to testing. The test consisted of a 
habituation period (5 minutes) followed by 2 testing phases (each 8 minutes). The 
habituation period was 5 minutes in which the rat was able to explore the center chamber. 
At the end of the 5-minute habituation, the doors were opened and the rat was able to 
explore an empty cage in one interaction chamber or a novel conspecific in the other 
interaction chamber. This first phase of testing analyzed social motivation, that is, the 
propensity to spend time with an unfamiliar rat. The second phase then analyzed social 
recognition. For the second phase of testing, a rat was placed in the previously empty 
cage, leaving the experimental animal with the choice to explore a new conspecific or the 
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conspecific from the first phase of testing. In this situation, control rats will spend 
significantly more time with the novel stranger, demonstrating a natural preference for 
social novelty. The locations of stranger versus novel rats in the left versus right side 
chambers were counterbalanced between trials.  
 
Locomotor/Open Field testing – Rats were placed in an automated open field activity 
chamber (Figure 3c; Med Associates, San Diego, CA, USA). Activity patterns were 
recorded for 60 minutes for the adolescent cohort and then shortened to 30 minutes for 
the adult cohort as adolescent animals spent most of the final 35 minutes sleeping and no 
longer moving. Analyses were performed over the total recording as well as over the first 
5 minutes of the recording as that is what is typical in the literature. Results presented 
here describes the first 5 minutes of the recording. Analyses looked at stereotypic 
movement, and time spent in the center, zone 1 area, of the open field chamber as well as 
the time spent along the walls, and residual area. Time spent in the zone 1 area is similar 
to the time spent in the light side of the light dark box, a test of anxiety-like behaviour, as 
rats have a natural aversion to the open and more vulnerable space (Ohl, 2003). This 
testing therefore also demonstrates the anxiogenic levels of the rats tested. 
 
Porsolt Forced Swim Test – In this well-established pre-clinical test for depressive-like 
phenotypes, rats were placed in a 70 x 19 cm cylinder filled ¾ of the way up with water 
for 15 minutes and behaviours were analyzed (Figure 3b). The main behaviours analyzed 
is immobility. Immobility is characterized by floating in the water with only movements 
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necessary to keep the nose above the surface (Bogdanova et al, 2013). This behaviour is a 
resigned behaviour that is considered a depressive-like behaviour in animal models of 
psychiatric disorders. The longer time spent immobile equates to a more depressive 
phenotype. A consideration that is important for the purposes of this thesis is the body 
weight of the rats. Previous work has described the significant effect of age and weight 
on the behaviours observed in testing (Bogdanova et al, 2013).   
 
Sucrose Preference Testing – The sucrose preference test is a measure of a rat’s intrinsic 
preference for sweet tasting substances, which serve as natural reward cues. The 
measurement of sucrose consumption therefore serves as a proxy for hedonic sensitivity, 
with a decrease in sucrose preference used as a proxy for anhedonia. For 24 hours before 
the test, rats were habituated to the procedure of being moved to a cage identical in size 
and shape to their own with fresh corn cob bedding and two bottles of water. They were 
habituated to these testing parameters for 1 hour. For 12 hours prior to testing, rats were 
water restricted to ensure rats were thirsty for testing. For testing, rats were moved to a 
cage identical in size and shape to their home cage with fresh corn cob bedding and two 
bottles, - one containing water and one containing a 2% sucrose solution. The amount of 
each consumed over a 1-hour period was measured and preference for sucrose solution 
was calculated. Sucrose preference testing is used in measures of anhedonia, a key 
characteristic in depression. Anhedonia describes the reduced ability to experience 
pleasure or rewarding stimuli, like a sucrose solution.  
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Figure 3. Diagram of behavioural apparatuses. A. Light dark box. B. Forced Swim test. C. 
Locomotor/Open field. D. Social Interaction – consisting of phase 1 and phase 2 each 8 minutes long as 
described in methods.  
 
2.22       Cognitive Tests 
 The cognitive tests were both conducted in an 80 x 80 cm open roofed arena. Rats 
were habituated to the arena 24 hours prior to testing for two sessions of 10 minutes, and 
then day of testing left to habituate to the room in which testing was performed for 30 
minutes prior to testing. Objects used in these tests were previously validated, and 
systematic biases to either object through the testing phase were counterbalanced for 
place preference. Tests were as follows: 
Phase 1 Phase 2 
Zone	1 
Residual	Area	 
A B C
D
27 
 
 
Object Recognition – For these experiments, rats were placed in the open field arena with 
two identical objects and rats were allowed to explore them for 5 minutes for an 
acquisition phase. One hour later rats were tested with an identical object from the 
acquisition phase and a novel object. In the testing phase rats were allowed to explore the 
two objects for 3 minutes (Figure 4a). In this situation, control rats will spend 
significantly more time with the novel object, demonstrating a natural preference for 
novelty.  Object recognition (OR) is a working memory task and requires the rat to 
recognize the previously explored object and is widely used to assess object recognition 
memory (Hannesson, Howland & Phillips, 2004). 
 
Object Recognition in Temporal Order – Similar to OR, object recognition in temporal 
order (ORITO) adds a second acquisition phase and tests two previously explored 
objects. In these experiments, acquisition phase one allows rats to explore two identical 
objects for 5 minutes. An hour later, two different identical objects are explored in a 
second 5-minute acquisition phase. One hour after that, the animal is tested with one 
object from each of the acquisition phases for 3 minutes (Figure 4b). In this situation, 
control rats will spend significantly more time with the object from the first acquisition 
phase, demonstrating a natural preference for less recently explored objects. ORITO is a 
higher order memory task also known as recency discrimination. On this test trial, normal 
rats spend more time exploring the old familiar object rather than the more recent familiar 
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object, requiring the animal to both recognize the previously explored objects as well as 
to discriminate their relative recency (Hannesson et al, 2004).  
All tests with the exception of sucrose preference and locomotor testing were 
video recorded with webcams (Logitech) and analyzed using a video-tracking system 
(ANY-maze; Stoelting) on PC computers using windows operating systems.  
 
 
 
Figure 4. Schematic of cognitive testing in open field arenas. A. Object Recognition. B. Object 
Recognition in Temporal Order Testing.  
 
2.3 In Vivo Neuronal Electrophysiology  
In Vivo neuronal electrophysiological recordings were performed unilaterally in 
the VTA, as previously described (Renard et. al, 2016). Rats were anesthetized with 
urethane (1.3 g/kg, i.p.)  and placed in a stereotaxic frame with a body temperature 
maintained at 37 oC. A scalp incision was made and a hole was drilled in the skull 
A 
B 
1 Hour 
1 Hour 1 Hour 
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overlaying the VTA, as well as a small hole for a screw in the skull overlaying the 
cerebellum. A grounding wire was then attached to the screw. For recordings, a glass 
microelectrode (with an average impedance of 6-8 MΩ), filled with a 2% pontamine sky 
blue solution in KCl, were lowered using a hydraulic micro-positioner (Kopf640) into the 
VTA. Coordinates were determined using the Paxinos and Watson rat atlas (1986) to the 
following coordinates: anterior/posterior: -5.2 mm from bregma, lateral: ±0.8-1 mm and 
dorsal/ventral: -6.5 to -9 mm from the dural surface. Extracellular signals were amplified 
using a Multiclamp700B amplifier (Molecular Devices) and recorded through a 
Digidata1440A acquisition system (Molecular Devices) using a pClamp10 software. 
Recordings were filtered at 1 kHz and sampled at 5 kHz. Analyses were performed 
offline using the Clampfit10 (Molecular Devices) software package.  
Predetermined track patterns were used to sample spontaneously active DA 
neurons in the VTA by moving 200 µm between each track. In each track presumed DA 
neurons were isolated and its spontaneous activity was recorded for 5 minutes. DA 
neurons within the VTA were identified according to previously established 
electrophysiological features (Ungless & Grace, 2012): 1) relatively long action potential, 
with a duration of >1.1 ms from the start to the negative trough; 2) a slow spontaneous 
firing rate (~2-5 Hz), and 3) a single irregular or bursting firing pattern. Non-DAergic 
cells were, conversely, higher in frequency with shorter AP durations. The two 
parameters of activity that were assessed were the basal firing rate and the proportion of 
spikes fired by the DA neurons that occurred in bursts. The onset of a burst was defined 
as the occurrence of 2 spikes with an inter-spike interval of 80 ms (Grace & Bunney, 
1983). The percentage of spikes in bursts was calculated by dividing the number of 
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spikes occurring in the bursts by the total number of spikes over the recorded period. 
Following recordings, recording electrode locations were marked with iontophoretic 
deposit of pontamine sky blue (-20 µA for 15 minutes). Animals were euthanized using 
Euthanyl (made in a 1:1 dilution of euthanyl-pentobarbital and ddH2O), decapitated and 
brains were removed, and stored in 10% formalin. Brains were sliced using a microtome 
at sections of 60 µm that were stained with neutral red to confirm the neuronal recording 
site. Cells recorded outside the anatomical boundaries of the VTA were excluded from 
data analysis.  
 
2.4 Molecular Analysis 
2.41 Extractions 
Rats were injected with 0.8 mL of Euthanyl (made in a 1:1 dilution of euthanyl – 
pentobarbital and ddH2O). Once the animal was on a surgical plane, (ex. no longer 
responded with reflexes to hind leg pinch or cornea touch) the animal was decapitated, 
the brain was quickly removed and blocked into coronal sections. Areas of interest were 
collected – targets based on the rat brain atlas (Paxinos and Watson, 1986). Tissue 
samples were placed in a homogenizer with lysis buffer (350 uL for mPFC, 600 uL for 
STR and 200 uL for SN). The tissue and liquid was then transferred to labelled eppendorf 
tubes. All tubes were rotated in the fridge for 30 minutes and then centrifuged at 10,000g 
for 10 minutes at 4oC. The pellet created from placing samples in the centrifuge was 
discarded and supernatant was transferred to a clean eppendorf tube. Of this liquid, 
aliquots were taken and placed in new eppendorf tubes, a loading buffer was added in a 
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1:1 ratio, boiled for 5 minutes and placed in the -80oC freezer to be used in blots. Left 
over liquid was labeled as count to further analyze for total protein count and stored in 
the -80oC freezer.  
 
2.42 Total Protein Count 
 Before running western blots, total protein count was analyzed in each of the 
samples in order to determine the volume of sample to be used to standardize total 
protein count across all samples. Two rows of standard protein concentrations were 
pipetted into the first two rows of wells on a 96- well loading assay plate followed by 
varying dilutions of the sample protein. Standard BSA protein concentrations ranged 
from 0-2000 ug. The samples were then diluted, incubated and quantified. The samples 
were quantified based on the colour of the sample as compared to the standard curve.  
 
2.43 Western Blots 
 Gels were cast, usually a 10% gel was made with some variation depending on 
the size of the protein of interest. Using the chart created following the total protein 
count, specific volumes of the total sample were aliquoted into a new eppendorf tube, 
2xLB buffer was then added to a final volume of 15 uL. Gels were assembled into the 
Western blot chamber with the fist running buffer, samples were loaded, the first well 
was the standard ladder on both gels and then samples alternated between control and 
nicotine. Gels were run at 125 V until the loading buffer reached the bottom of the gel 
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(about an hour and 15 minutes). After samples were run through the gel, they were 
transferred to nitrocellulose. The whole transfer apparatus was placed in a bucket 
surrounded by ice to control temperature. The gels were run at 75 V for 60-70 minutes. 
Once removed from the transferring process the nitrocellulose was cut down to the size of 
the gel. It was then placed in a container with TBS-T on a rocker to wash the transfer 
buffer away. The blot was then moved to a blocking solution, which was left on the 
rocking nitrocellulose for 45 minutes - 1 hour. From here the primary antibody was made 
up in either a dehydrated milk/TBS-T solution or a BSA/TBS-T solution depending on 
the antibody. After washing the blocking solution from the blot, the primary antibody 
was put on the nitrocellulose and it was left to rock in the fridge overnight. Primary 
anibody dilutions were as follows: α-tubulin (1: 120 000; Sigma-Aldrich), 
phosphorylated ERK1/2 [T202/Y204] (pERK1/2; 1: 2000; Cell Signaling Technology), 
total ERK1/2 (tERK1/2; 1:5000, Cell Signaling Technology), phosphorylated CaMKIIα 
[T286] (pCaMKIIα; 1:10 000; Cell Signaling Technology), total CaMKIIα (tCaMKIIα; 
1:5000; Cell Signaling Technology), D1R (1:100; Santa Cruz Biotechnology), and D2R 
1:100; Santa Cruz Biotechnology). The next morning the rocker with all of the 
nitrocellulose/primary antibody containers was brought out to return to room 
temperature. Once room temperature was again reached, the primary antibody was 
washed off the blot and the secondary antibody was applied and left on the rocking blots 
for one hour. Secondary antibodies (Thermo Scientific) were all used at a dilution of 1:20 
000. The secondary antibody was prepared in a BSA/TBS-T solution. The blots were 
washed a final time and at this point ready to be read by the Licor processing machine to 
visualize the protein bands and eventually be quantified. Once the bands were visualized 
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and turned into a .tiff image, the band intensity was quantified and normalized to the 
alpha tubulin loading control. Normalized samples were then compared as a function of 
change from control samples.  
 
 2.5 Statistical Analyses 
Behavioural and electrophysiological data were analyzed with ANOVAs and t-
tests, where appropriate. All statistical analyses were run using SPSS Statistics software 
and only values with p≤ 0.05 were considered as significant and outliers of more than 2 
standard deviations away from the mean were excluded from analyses. 
 
 
3 Results  
 
3.1 The Effects of Adolescent Nicotine Exposure 
3.11 Behavioural Results 
The first set of experiments performed looked at behavioural differences that resulted 
from adolescent nicotine exposure. Behavioural paradigms were all run 31 days after the 
chronic exposure to nicotine or a saline control, at PND 75. There were no 
pharmacological interventions after the adolescent protocol.  
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a. Locomotor & Open Field Testing 
Rats were placed in an open field arena and left to explore, and freely move through 
arena over 60 minutes. Movement patterns and distances were recorded and analyzed 
using an automated activity monitor. Over the full 60 minutes of the recording there were 
no statistical differences in the total movement of the two groups of rats. The total 
distance travelled by each over the 60-minute test was 3651 cm for the vehicle group (SD 
= 375.85) and 2726.89 cm for the nicotine group (SD = 430.31). As the test progressed, 
rats spent a larger proportion of the time immobile and ultimately ended up sleeping in a 
corner of the apparatus, as described in figure 5A. Due to the amount of time spent 
immobile in the second half of the test, as well as the standard of analyzing the first 5 
minutes of an open field test, only the first block of time was examined further for 
behavioural differences. Over the first 5 minutes, the two groups did not differ from one 
another with total movement (M = 846.3 cm, SD = 120.81 for nicotine, M = 1031.23, SD 
= 90.16 for vehicle). In the first 5-minutes, the adolescent nicotine group spent 
significantly less time, and travelled less distance in the zone one area as compared to the 
vehicle group (t (18) = 2.787, p = 0.012; t (18) = 2.522 p = 0.021 respectively; Figure 5). 
Conversely, the adolescent nicotine group also spent significantly more time in the 
residual area (t (18) = 2.704, p = 0.015; Figure 5). The nicotine group spent about 4x more 
time in the residual area as compared to the vehicle group. They also spent about half the 
amount of time in the zone one area as compared to the vehicle group (Figure 5). 
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Figure 5. Adolescent Open Field and Locomotor Testing. In all charts Blue = adolescent vehicle, Grey= 
adolescent nicotine. N = 10 per group. A. Ambulatory distance in 5 minute blocks for the full 60 minutes of 
testing (each block represents 5 minutes of testing; Bock 1 = 0-5 minutes, block 2 = 6-10 minutes etc.). 
There were no statistically significant differences between the adolescent nicotine and adolescent vehicle 
groups, with respect to distance traveled, at any of the time points through testing. B. Total distance 
travelled in zone 1 (the center portion of the open field apparatus) over the first 5 minutes of locomotor 
testing. Adolescent nicotine rats travelled significantly less distance in the zone 1 area (p = 0.021). C. Total 
distance travelled in the residual area (the surrounding wall portion of the open field apparatus) over the 
first 5 minutes of locomotor testing. Rats did not significantly differ in distance travelled in the residual 
area (p = 0.236). D. Total time spent in zone 1 (the center portion of the open field apparatus) over the first 
5 minutes of locomotor testing. Adolescent nicotine rats spent significantly less time in the zone 1 area (p = 
0.012). E. Total time spent in the residual area (the surrounding wall portion of the open field apparatus) 
over the first 5 minutes of locomotor testing. Adolescent nicotine rats spent significantly more time in the 
residual area compared to the vehicle group (p = 0.012). F. Pictogram of adolescent nicotine animal’s 
movement patterns over 60 minutes of locomotor testing. G. Schematic of open field apparatus with zone 1 
and residual areas labelled. H. Pictogram of adolescent vehicle animal’s movement patterns over 60 
minutes of locomotor testing. Error bars represent mean ±SE for all figures. 
* 
** ** 
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b. Light-Dark	Box	Testing	
Rats were initially placed in the light side of the light-dark box. The first latency, the 
time it took from the beginning of the testing, to the time the animal entered into the dark 
side of the box, was taken. There was a trend that the adolescent nicotine pretreated rats 
took longer to run into the dark side, as compared to the vehicle group (t (10.176) = 0.052, p 
= 0.052; Figure 5D). The vehicle group took about 10 seconds to run into the dark side 
(SD = 6.62), while the nicotine group took just under 20 seconds to run into the dark side 
(SD = 12.11). The second latency calculated was the time taken from arriving in the dark 
side of the box to then re-enter the light side. In this measure, there was no statistical 
difference between the two groups, as the nicotine group demonstrated quite a bit of 
variability in their responses (t (9.218) = 1.476, p = 0.173; Figure 6E). The vehicle group 
took just over 20 seconds, on average, to return back to the light side (SD = 20.17), while 
the nicotine group took more than twice the amount of time at almost 1 minute to return 
to the light side (SD = 76.96; Figure 6E). It is important to note here, that one animal 
from the nicotine group was excluded from the analysis as he did not return to the light 
side, spending the rest of the test in the dark side. Over the 8 minutes of testing, the rats 
in the nicotine group, on average, spent significantly more time in the dark side, and 
conversely significantly less time in the light side of the box, as compared to the vehicle 
group (t (18) = 2.240, p = 0.038; t (18) = 2.294 p = 0.034 respectively; Figure 6B-C).  The 
adolescent nicotine group spent, on average, 100 seconds in the light side of the box (SD 
= 59.65) and 350 seconds in the dark side (SD = 59.97), compared to the vehicle group, 
that spent 160 seconds in the light side (SD = 41.69) and about 300 seconds in the dark 
side (SD = 39.73; Figure6B-C). Over the course of the 8-minute test, the groups did not 
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differ in their transitions between the two compartments (Figure 6F). Both groups 
transitioned between the two compartments between 15 and 20 times over the course of 
the testing (M = 19.4, SD = 4.33 for vehicle, M = 15.3, SD = 9.04 for nicotine).  
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Figure 6. Adolescent Light–Dark Box Testing. In all charts Blue = adolescent vehicle, Grey= adolescent 
nicotine. N = 10 per group. A. Schematic of light dark box arena. B. Average time spent in the dark side of 
the light-dark box over the 8 minutes of testing. The adolescent nicotine group spent significantly more 
time in the dark side of the light-dark box (p = 0.034). C. Average time spent in the light side of the light-
dark box over the 8 minutes of testing. The adolescent nicotine group spent significantly less time in the 
light side of the light-dark box (p = 0.034). D. Latency 1 describes the time it took the animal to run from 
the light side into the dark side of the box from the beginning of the test. The two groups did not 
statistically significantly differ from one another on this measure. E. Latency 2 describes the time it took 
the animal to run from the dark side into the light side of the box from the beginning of the test. The two 
groups did not statistically significantly differ from one another. F. Total transitions over the 8-minute 
testing period. 
* * 
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c. Social	Interaction	Testing	
Social Interaction Testing is made up of two 8-minute testing phases. In the first 
phase, the animal has the option to explore either an empty cage or a rat that they had 
never interacted with before. Comparing exploration of the novel conspecific versus an 
empty cage in phase one, a two way repeated measures ANOVA revealed a significant 
effect of treatment (F (1, 33) = 5.319, p = 0.028). Post hoc comparisons revealed that the 
difference between the two groups being the adolescent nicotine group spent less time 
exploring the stranger rat as compared to the adolescent vehicle pretreated group (p = 
0.05; Figure 7). The vehicle group spent, on average, 30 seconds more exploring the 
stranger in phase one than the nicotine group (M = 127.61, SD = 31.68 for vehicle, M= 
105.46, SD = 29.45 for nicotine; Figure 7). Furthermore, in each phase, both the nicotine 
and vehicle pretreated groups demonstrated a main effect preference, for the stranger rat 
as opposed to an empty cage (p < 0.001). The second phase of testing takes place 
immediately after the first. For the second phase of the testing, the animal has the option 
to explore either the rat from the first phase of experiments or a new stranger rat placed in 
the previously empty cage. In this 8-minute test, results from a two way repeated 
measures ANOVA revealed a significant effect of treatment (F (1,33) = 5.303, p = 0.028). 
Again, there was a difference between the two groups with respect to the amount of time 
they explored the novel rat. Post hoc comparisons, describe the adolescent nicotine group 
spent less time exploring the novel rat as compared to the vehicle group (p < 0.05; Figure 
7).  The vehicle group spent, on average, more than 40 seconds more, than the adolescent 
nicotine group, exploring the newest conspecific (M = 122.25, SD = 50.37 for vehicle, M 
40 
 
= 85.68, SD = 30.47 for nicotine; Figure 7).  Again there was a main effect of preference 
for the novel conspecific (p < 0.001).  
 
      
Figure 7. Adolescent Social Interaction Testing. Blue = adolescent vehicle, Grey= adolescent nicotine. N 
= 20 per group. Adolescent nicotine rats spent significantly less time exploring the stranger rats in both the 
first and second phases of the experiment (p = 0.05, p = 0.046 respectively). In both phases of the test, both 
groups demonstrated a preference for the novel conspecific (p < 0.001).  
 
 
d. Sucrose Preference Testing 
After 12 hours of water deprivation, rats were placed in a cage with two water bottles, 
one bottle containing a 2% sucrose solution and one bottle containing tap water. After 1 
hour of exploration and liquid consumption, total liquid changes were calculated. In 
terms of average 2% sucrose solution consumed, the groups did not statistically differ in 
terms of amount consumed (t(18) = 0.827, p = 0.419; Figure 8A). It appears, though, that 
the adolescent nicotine group, on average, consumed less of the sucrose solution than the 
vehicle group (M = 11.55, SD = 6.05 and M = 14.6, SD = 4.2, respectively). Conversely, 
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the adolescent nicotine group consumed significantly more water than the adolescent 
vehicle group over the course of testing (M = 6.81, SD = 5.25 and M = 2.8, SD = 2.57 
respectively; t(18) = 2.645, p = 0.016; Figure 8B). Through the testing, the groups 
consumed similar amounts of liquid, about 18 mL, with the group differences being in 
which liquid they preferred to consume (M = 17.4, SD = 2.99 for vehicle, M = 18.36, SD 
= 3.93 for nicotine). The vehicle group consumed 15 mL (SD = 4) of the 2% sucrose 
solution and 3 mL (SD = 2.5) of the water, while the nicotine group consumed 11 mL 
(SD = 6) of the 2% sucrose solution and 7 mL (SD = 5) of the water (Figure 8). There 
was a significantly lower preference for the 2% sucrose solution in the adolescent 
nicotine group as compared to the adolescent vehicle group (t(18) = 2.393, p = 0.028; 
Figure 8D). The adolescent nicotine group had about a 62% (SD = 28) preference for the 
sucrose solution as compared to the vehicle group that had an 83% (SD = 18) preference 
for the sucrose solution (Figure 8D).  
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Figure 8. Adolescent Sucrose Preference Testing. In all charts Blue = adolescent vehicle, Grey= 
adolescent nicotine. N = 10 per group. A. The amount of the 2% sucrose solution consumed over the 1-hour 
test. The two groups did not statistically differ from one another, while there was a trend in the data 
suggesting the adolescent nicotine rats consumed less of the solution (p = 0.173). B. The amount of the tap 
water consumed over the 1-hour test. The adolescent nicotine group consumed significantly more water 
than the vehicle group (p = 0.016). C. The total amount of liquid consumed over the 1-hour test. The two 
groups consumed similar amounts of liquid in total through the test. D. The preference for the 2% sucrose 
solution. The adolescent vehicle group had a significantly greater sucrose preference as compared to the 
nicotine group (p = 0.028). 
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e. Forced	Swim	Testing	
In forced swim testing, the animal is placed in the tube of water for 15 minutes and 
the resulting behaviours were analyzed. The main behaviours analyzed are time spent 
swimming, time spent climbing the walls and time spent immobile (Bogdanova et al., 
2013). Over the test, the adolescent nicotine group spent significantly less time 
swimming, as compared to the vehicle group (t (18) = 3.140, p = 0.006; Figure 9). The 
vehicle group spent, on average, 559.82 seconds swimming (SD = 75.64), while the 
nicotine group spent 432.23 seconds swimming (SD = 103.87; Figure 9). Both groups 
spent less time immobile than swimming but the two groups significantly differed from 
one another with the adolescent nicotine pretreated rats spending significantly more time 
immobile, compared to the adolescent vehicle pretreated rats (t (18) = 2.549, p = 0.02; 
Figure 9). The adolescent nicotine group spent, on average, 341.06 seconds immobile 
over the test (SD = 124.46), while the vehicle group spent, on average, 221.09 seconds 
immobile (SD = 77.34). Both groups performed similarly when the climbing behaviour 
was analyzed. Both groups spent around 115 seconds climbing (M = 110.92, SD = 26.71 
for vehicle, M = 123.41, SD = 79.85 for nicotine). The behaviour of climbing was typical 
to the beginning of the test as the initial behaviour observed. This usually lasted for the 
first few minutes of the test until the rats began the swimming behaviour and exploratory 
dives.  
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 Figure 9. Adolescent Forced Swim Testing. Blue = adolescent vehicle, Grey= adolescent nicotine. N = 
10 per group. The amount of time over a 15-minute testing period spent swimming, climbing or immobile. 
The adolescent nicotine pretreated group spent significantly less time swimming (p = 0.006) and 
significantly more time immobile (p = 0.02) over the testing. Both groups spent similar time climbing.  
 
3.12 Cognitive Results  
The next set of experiments performed, looked at cognitive differences that resulted 
from adolescent nicotine exposure. Cognitive paradigms were all run 31 days after the 
chronic exposure to nicotine or a saline control, at PND 75. There were no 
pharmacological interventions after the adolescent protocol.  
 
a. Object Recognition 
To assess memory cognition, object recognition testing was performed. Object 
recognition assesses memory and is linked to hippocampal activity (Mumby, 2001). 
Object recognition plays on the rats’ natural preference for novel things. Control rats 
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typically display similar amounts of time exploring the pair of identical objects during the 
training phase, and then a longer time exploring the novel object during the testing phase 
of this paradigm. Both the adolescent nicotine as well as the adolescent vehicle groups 
performed at the same level (Figure 10). In the training phase, a two way repeated 
measures ANOVA describes no effect of treatment on time spent exploring the two 
identical objects (F (1, 17) = 0.005, p = 0.946; Figure 10). During the testing phase, a two 
way repeated measures ANOVA again does not describe a treatment effect on the time 
spent exploring the two objects (F (1, 17) = 0.016, p = 0.901). The ANOVA did however 
describe a significant main effect with both the vehicle and nicotine groups spending 
significantly more time exploring the novel object (F (1, 17) = 20.817, p < 0.001; M = 
27.20, SD = 12.62 and M = 28.36, SD =6.72, respectively) as compared to the object 
identical to those in the training phase (M =15.07, SD = 5.49 for vehicle, and M = 16.88, 
SD = 6.60 for nicotine; Figure 10). The groups performed at the same level in all aspects 
of this task.  
 
46 
 
 
 
0
5
10
15
20
25
30
35
Sniff 1 Sniff 2 Known Object Novel Object
Ti
m
e 
Sp
en
t S
ni
ffi
ng
 (S
) 
Testing Phase Training 
Phase 
* 
* 
Figure 10. Adolescent Object Recognition Testing. Blue = adolescent vehicle, Grey= adolescent 
nicotine. N = 10 per group. In the training phase of the testing, both groups spent similar time exploring an 
identical set of objects. In the testing phases of the test, both groups demonstrated a preference for the 
novel object (p = 0.02 for vehicle, p = 0.006 for nicotine).  
  
b. Object	Recognition	in	Temporal	Order	
To further explore cognitive memory, object recognition in temporal order was 
performed on all rats. This test takes the requirements from object recognition, explained 
previously, and adds a second training phase with a different pair of objects. Finally, the 
testing phase consists of one of each of the objects previously explored. Adding in the 
second training phase forces the animal to not only remember the first object but the 
second as well as integrating that information in the testing phase of this task. In training 
phase one, both the adolescent nicotine and adolescent vehicle groups explored both sets 
of the object equally, there were no differences between the groups (for vehicle: M = 
20.67, SD = 7.61 and M = 21.43, SD = 9.82, for nicotine: M = 24.24, SD = 9.43 and M = 
19.28, SD = 11.33; Figure 11A). A two way repeated measures ANOVA describes no 
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changes no effect of treatment on exploration during the first phase (F (1, 17) = 0.368, p = 
0.552). In the second phase of training, there was no treatment effect between the two 
adolescent groups, nor was there a difference between the time spent exploring the two 
identical objects (F (1, 17) = 0.205, p = 0.656; for vehicle: M = 22.35, SD = 7.33 and M = 
15.89, SD = 8.68, for nicotine: M = 15.24, SD = 11.47 and M = 10.46, SD = 7.70; Figure 
11B). In the testing phase of the task, a two way repeated measures ANOVA describes an 
effect of treatment on the exploration (F (1,17) = 4.654, p = 0.046). The adolescent nicotine 
and adolescent vehicle groups spent similar amounts of time exploring the object from 
the second phase of testing (M = 9.54, SD = 7.90 for vehicle, M=11.33, SD = 7.47 for 
nicotine), but the adolescent nicotine group spent less time exploring the first object (M = 
18.12, SD = 12.90 for vehicle, M = 9.91, SD = 5.99 for nicotine; Figure 11C). The 
adolescent nicotine group spent around the same amount of time exploring both the 
object from the first and the object from the second phases of testing, while the 
adolescent vehicle group spent significantly more time exploring the object from the first 
phase of testing when compared to the amount of time spent exploring the object from 
the second phase of testing (p = 0.041; Figure 11D). In the object recognition in temporal 
order testing the two groups only differed on the testing phase of the task, the adolescent 
vehicle group spent significantly more time exploring the object from the first training 
phase as compared to both the second training phase and the adolescent nicotine group 
(Figure 11).  
48 
 
 
 
 
0
5
10
15
20
25
30
1 2
Ti
m
e 
(s
)
Training Phase 1
0
5
10
15
20
25
Exploring Phase 1 
Object
Exploring Phase 2 
Object 
Ti
m
e 
(s
)
0
5
10
15
20
25
30
1 2
Ti
m
e 
(s
)
Training Phase 2
0
5
10
15
20
25
VEH NICOTINE
Ti
m
e 
(s
)
OLD
RECENT
A B 
C D * 
* 
 Figure 11. Adolescent Object Recognition in Temporal Order Testing. Blue = adolescent vehicle, 
Grey= adolescent nicotine. N = 10 per group. A. Training phase 1 of the task, two identical objects were 
explored. Bars represent the amount of time spent exploring the two identical objects. The vehicle and 
nicotine group did not differ in their time spent exploring the two objects. B. Training phase 2 of the task, 
two different identical objects were explored. Bars represent the amount of time exploring the two identical 
objects. The vehicle and nicotine group did not differ in their time spent exploring the two objects. C-D.  
The testing phase of the task represented as he two objects (one from the first and one from the second 
phase of training) and then as the two groups (adolescent nicotine and adolescent vehicle) to best visualize 
the differences. The adolescent nicotine group spent similar amounts of  time exploring the two objects 
while the vehicle group spent significantly more time exploring the object from training phase 1 as 
compared to training phase 2 (p = 0.041). D. Black = object from the first phase of training, Grey = object 
from second phase of testing.  
 
3.13 Electrophysiology Results 
In Vivo electrophysiology was performed in the VTA to measure baseline firing patterns 
of dopaminergic neurons within the VTA. Electrophysiological paradigms were all run 
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31 days after the chronic exposure to nicotine or a saline control, at PND 75. There were 
no pharmacological interventions after the adolescent protocol. Over the 5 minute 
recordings, the cell frequency and bursting behaviour was analyzed. Results from these 
recordings indicated an increase in dopaminergic cell frequency as well as bursting in the 
adolescent nicotine group as compared to the adolescent vehicle group. In cell frequency, 
the adolescent group pretreated with nicotine, had more than a 3x greater frequency at 4.2 
Hz (SD = 2.98) as compared to the adolescent group pretreated with a vehicle solutions 
1.5 Hz (SD = 0.79; Figure 12C). This describes a significantly more active cell 
population with respect to action potentials in the adolescent nicotine group (t(9.116) = 
2.655, p = 0.026). Furthermore, the adolescent nicotine group also had a significantly 
higher burst rate (M = 43.73, SD = 32.04 for nicotine, M = 13.62, SD = 9.86 for vehicle) 
and a significantly higher average bursts in the recordings (t(9.502) = 2.695, p = 0.023, 
t(13.288) = 2.047, p = 0.023, respectively; Figure 11D-E). In burst rate, the adolescent 
nicotine group again had a value more than three times the size of that in the adolescent 
vehicle group. The adolescent nicotine group had a burst rate of 43.7 bursts while the 
adolescent vehicle group only had a burst rate of 13.6 bursts (Figure 12D). Over the 
course of the recording, the average number of bursts was calculated for each treatment 
group. The adolescent nicotine group averaged 218.7 bursts during the entire recording 
(SD = 160.20), while the adolescent vehicle group averaged 68.1 bursts over the 
recording period (SD = 49.30). This describes a marked difference in both bursting and 
cell firing behaviours between the adolescent nicotine group and the adolescent vehicle 
group. 
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Figure 12. Adolescent Electrophysiological Recordings from the VTA. Blue = adolescent vehicle, 
Grey= adolescent nicotine. N = 9 cells per group obtained from 3 nicotine and 2 vehicle animals. A. 
Representative baseline single cell baseline recordings of adolescent nicotine and adolescent vehicle rats 
demonstrating the increase in firing among the adolescent nicotine group. B. Average cell frequency over 
the duration of the recording. Adolescent nicotine pretreated rats had a significantly higher baseline firing 
frequency when compared to the adolescent vehicle group (p = 0.026). C. Average burst rate. The 
adolescent nicotine group had a significantly higher burst rate as compared to the adolescent vehicle group 
(p = 0.023). D. The average bursts over the duration of the recording. The adolescent nicotine pretreated 
group again had a significantly greater number of bursts over the recording as compared to the adolescent 
vehicle group (p = 0.023). E.  Diagram of the location of the In Vivo electrophysiological recordings as 
well as a representative stained section describing the location of the final recording.  
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3.14 Molecular Results  
Due to the results found in the In Vivo electrophysiology experiments, further 
molecular analyses were performed to better characterize some of the long term changes 
in the PFC, a structure innervated by the mesolimbic pathway, that originates in the VTA. 
Therefore, tissue from the PFC was analyzed using a western blot technique. Molecular 
analyses were all run 31 days after the chronic exposure to nicotine or a saline control, at 
PND 75. There were no pharmacological interventions after the adolescent protocol. Data 
was normalized to the loading control and is presented as a percentage change from the 
vehicle group. Based on the changes in DA firing, dopaminergic receptor densities were 
analyzed. The adolescent nicotine and adolescent vehicle groups did not significantly 
differ from one another in terms of D2 receptor levels (Figure 13C).  With the adolescent 
vehicle group representing 100% (SD = 9.9), the nicotine group is at a level of 96% (SD 
= 12.7) meaning the D2 receptor levels in the two groups were relatively similar. The two 
groups did, however, differ in D1 receptor concentrations. There was a significant 
downregulation in D1 receptor levels in the adolescent nicotine levels. The adolescent 
nicotine group was at 77% (SD = 11.5) of the adolescent vehicle group, demonstrating 
that, when compared to the vehicle group, the adolescent nicotine group had a significant 
reduction in the total levels of D1 receptors in a one tailed test (t (6) = 2.822, p = 0.015, 
Figure 13B). 
 Based on previous work in our lab, regarding changes in the PFC following 
adolescent THC exposure, similar electrophysiological results were obtained (Renard et 
al., 2016). Based on molecular pathways examined and found to have changed in these 
results as well as knowledge of the functions of these molecules and their respective 
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pathways, ERK1/2 and CaMKII were both quantified in the samples. Looking at both the 
total CaMKII and just the phosphorylated form of CaMKII, there were no significant 
changes in the levels between the adolescent nicotine and adolescent vehicle groups. 
CaMKII is activated when phosphorylated, therefore, it is important to look at both the 
phosphorylated as well as total levels to see any potential changes in the ratios of 
active/inactive levels. In these experiments, there were no changes in either 
phosphorylated nor total levels of CaMKII, therefore no changes to this ratio. Total levels 
of pCaMKII for the nicotine group were at 99.5% (SD = 20.0) when compared to the 
levels found in the vehicle group (M = 100, SD = 6.5; Figure 13D). In total CaMKII 
levels, the nicotine group was at 97% (SD = 8.4) to the 100% (SD = 8.1) vehicle levels 
(Figure 13D). When looking at the results from ERK, the two groups significantly 
differed from one another. Again, ERK is a molecule that is activated through 
phosphorylation, therefore, we must look at both the phosphorylated as well as total 
levels of ERK. ERK also consists of two substrates noted ERK1 and ERK2. Both serve 
similar functions but appear as two distinct bands on western blots due to their difference 
in size (Figure 13A). In terms of total levels of ERK1/2 the adolescent nicotine group did 
not significantly differ from the vehicle controls (Figure 13A). For ERK1the two groups 
only differed by 0.5% (M = 99.5, SD = 8.7 for nicotine, M= 100, SD = 6.2 for vehicle), 
and for ERK2, the nicotine group was at 98% (SD = 5.0) of the vehicle levels (M = 100, 
SD = 6.1; Figure 13A). Neither of these differences were significant as they were too 
similar, especially given the spread of the data. The adolescent nicotine pretreated group 
did however differ from the adolescent vehicle pretreated group in levels of activated 
(phosphorylated) ERK1/2. In pERK1, the nicotine group expressed a 4-fold increase (M 
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= 447 for nicotine and M = 100 for vehicle), and in pERK2, they showed a 5-fold 
increase in a one tailed test (M = 531, SD = 310 for nicotine and M = 100, SD = 39.9 for 
vehicle; t (6) = 2.300, p = 0.03 and t(6) = 2.747, p = 0.016 respectively; Figure 13A). With 
total levels of ERK1/2 remaining the same, this demonstrates a large difference in the 
ratio of activated/inactivated ERK levels. This demonstrates that adolescent nicotine rats 
had persistent changes in pERK1/2 levels with a substantial increase in the activated form 
of ERK1/2.   
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 Figure 13. Adolescent Molecular Analysis of PFC. Blue = adolescent vehicle, Grey= adolescent 
nicotine. N = 4 per group. A. Relative concentrations of phosphorylated ERK1/2, total ERK1/2 in nicotine 
rats compared to the vehicle pretreated group. The nicotine group had a significantly larger concentration 
of phosphorylated ERK1 and ERK2 (p (one tail) = 0.03 and p (one tail) = 0.016 respectively) . There were 
no significant differences between the groups with respect to total ERK1 or ERK2 concentrations.  B. 
Relative concentrations of D1 receptors in nicotine rats compared to the vehicle group. The adolescent 
nicotine group had a significantly smaller concentration of D1 receptors as compared to the vehicle group ( 
p (one tail) = 0.015). C. Relative concentrations of D2 receptors in nicotine rats compared to the vehicle 
group. There were no significant differences between the groups with respect to total D2DR concentrations. 
D. Relative concentrations of total and phosphorylated CaMKII. There were no significant differences 
between the nicotine and vehicle groups with respect to total as well as phosphorylated concentrations.   
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3.2 The Effects of Nicotine Exposure in Adult Rats 
3.21 Behavioural Results 
Following the robust changes found following adolescent nicotine exposure, it was 
important to then further describe the changes as being a function of the developmental 
period as opposed to a general long term result of nicotine. Behavioural paradigms were 
run 31 days after the chronic exposure to nicotine or a saline control, at PND 105. There 
were no pharmacological interventions after the adult exposure protocol.  
 
a. Locomotor & Open Field Testing 
Rats were placed in an open field arena and left to explore and freely move through 
arena over 30 minutes. Movement patterns and distances were recorded and analyzed 
using an automated activity monitor. Over the full 30 minutes of the recording there were 
no statistically significant differences in the total movement of the two groups of rats (M 
= 2118.01, SD = 212.27 for vehicle, M = 2364.79, SD = 177.49 for nicotine). In all 
measures, there was no statistical differences between the nicotine or vehicle groups. 
Over the first 5 minutes, the two did not differ in total distance travelled (M = 675.187, 
SD = 98.43 for vehicle and M = 774.82, SD = 87.42 for nicotine; t (18) = 0.757, p = 
0.459). Furthermore, the nicotine and vehicle groups did not differ from one another in 
the distance travelled in zone 1 (M = 182.83, SD = 109.74 for vehicle, M = 208.96, SD = 
110.41 for nicotine; t (18) = 0.686, p = 0.502) nor in the residual area (M = 492.36, SD = 
229.89 for vehicle, M = 565.86, SD = 249.02 for nicotine; t (18) = 686, p = 0.502; Figure 
14B-C). Furthermore, the two groups spent similar amounts of time exploring and resting 
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in the zone 1 area (M = 55.5, SD = 34.97 for vehicle, M = 49.9, SD = 25.12 for nicotine; t 
(18) = 0.411, p =  0.686) as well as in the residual area (M = 286.5, SD = 39.16 for 
vehicle, M = 283.9, SD = 28.02 for nicotine; t (18) = 0.411, p = 0.686; Figure 14D-E). The 
pictograms in figure 14 demonstrate movement patterns of a vehicle and nicotine animal 
over the course of testing. In this case it appears that both rats move in similar non-
specific patterns through the residual and zone one areas. In general, rats will spend more 
time in the residual area but both groups spent a similar amount of time exploring the 
zone 1 area.  
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Figure 14. Adult Open Field and Locomotor Testing. In all charts Orange = adult vehicle, Yellow = 
adult nicotine. N=10 per group. A. Ambulatory distance in 5 minute blocks for the full 60 minutes of 
testing (each block represents 5 minutes of testing; Bock 1 = 0-5 minutes, block 2 = 6-10 minutes etc.). 
There were no statistically significant differences between the adult nicotine and adult vehicle groups, with 
respect to distance traveled, at any of the time points through testing. B. Total distance travelled in zone 1 
(the center portion of the open field apparatus) over the first 5 minutes of  locomotor testing. There were no 
statistical differences between the two groups in distance travelled through zone 1. C. Total distance 
travelled in the residual area (the surrounding wall portion of the open field apparatus) over the first 5 
minutes of  locomotor testing. There were no statistical differences between the two groups in distance 
travelled through the residual area. D. Total time spent in zone 1 (the center portion of the open field 
apparatus) over the first 5 minutes of  locomotor testing. There were no statistical differences between the 
two groups in time spent in zone 1. E. Total time spent in the residual area (the surrounding wall portion of 
the open field apparatus) over the first 5 minutes of  locomotor testing. There were no statistical differences 
between the two groups in time spent in the residual area. F. Pictogram of adult nicotine animal’s 
movement patterns over 60 minutes of  locomotor testing. G. Schematic of open field apparatus with zone 
1 and residual areas labelled. H. Pictogram of adult vehicle animal’s movement patterns over 60 minutes of 
locomotor testing. 
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b. Light	Dark	Box	Testing	
Rats were placed in the light side of the light-dark box. The first latency, the time it 
took from the beginning of the testing to going into the dark side of the box, was taken. 
There weren’t any significant differences between the two groups while the nicotine 
group tended to take longer to go into the dark side (Figure 15D; t (18) = 1.887, p = 
0.075). In general, the two groups took longer times than the adolescents appeared to. 
The adult vehicle group took, on average, 32 seconds to run into the dark side (SD = 
23.06), while the nicotine group took, on average, 56.3 seconds to run into the dark side 
(SD = 33.57; Figure 15D). The second latency calculated is the time taken from arriving 
in the dark side of the box to then re-enter the light side. There again were no significant 
differences between the two groups (t (18) = 0.216, p = 0.832). Both groups took about 70 
seconds to return to the light side of the box from the dark side (M =67.2, SD = 88.45 for 
vehicle, M = 74.5, SD = 60.29 for nicotine; Figure 15E). Over the 8 minutes of testing, 
both groups spent over 300 seconds in the dark side (M = 303.93, SD =81.26 for vehicle, 
M = 318.04, SD = 32.55 for nicotine) and less than 200 seconds in the light side of the 
box (M = 173.73, SD = 79.89 for vehicle, 158.7, SD = 29.93 for nicotine; Figure 15B-C). 
Neither group significantly differed from the other (t (18) = 0.557, p = 0.584 for time spent 
in light side, t (11.851) = 0.510, p = 0.620). In general, both the adult nicotine and adult 
vehicle groups performed at similar levels in all measures of the testing. Both groups 
were similar in total transitions between the two compartments, with the vehicle group 
transitioning 14.1 times throughout testing (SD = 4.07), and the nicotine group 
transitioning 12.2 times throughout testing (SD = 4.78; t (18) = 0.957, p = 0.351).  
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Figure 15. Adult Light-Dark Box Testing. In all charts Orange = adult vehicle, Yellow = adult nicotine. 
A. Schematic of light dark box arena. B. Average time spent in the dark side of the light-dark box over the 
8 minutes of testing. Adult nicotine and vehicle groups did not significantly differ from one another. C. 
Average time spent in the light side of the light-dark box over the 8 minutes of testing. Adult nicotine and 
vehicle groups did not significantly differ from one another. D. Latency 1 describes the time it took the 
animal to run from the light side into the dark side of the box from the beginning of the test. The two 
groups did not statistically significantly differ from one another on this measure. E. Latency 2 describes the 
time it took the animal to run from the dark side into the light side of the box from the beginning of the test. 
The two groups did not statistically significantly differ from one another. F. Total transitions through 
testing. 
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c. Social	Interaction	Testing	
Social Interaction Testing is made up of two 8-minute testing phases. In the first 
phase, the animal has the option to explore either an empty cage or a rat that they had 
never interacted with before. In this, both the nicotine and vehicle pretreated groups 
demonstrated a preference for the stranger rat as opposed to an empty cage. In the first 
phase of testing, a two way repeated measures ANOVA reveals no effect of treatment on 
exploration (F (1, 13) = 0.763, p = 0.398). Both adult pretreated groups spent similar 
amounts of time exploring both the stranger (M = 118.38, SD = 44.69 for vehicle, M = 
138.36, SD = 56.03 for nicotine), and the vehicle group spent more time exploring the 
empty cage (M = 56.03, SD = 14.62 for vehicle, M = 24.17, SD = 20.41 for nicotine; 
Figure 16). Both groups spent more than 120 seconds exploring the stranger rat and less 
than a minute exploring the empty cage, with both groups showed a significant 
preference for the novel conspecific (p < 0.001; Figure 16). The second phase of testing 
takes place immediately after the first. For the second phase of the testing, the rats have 
the option to explore either the rat they previously explored in the first phase of 
experiments or a new stranger rat placed in the previously empty cage. In this 8-minute 
test, both the nicotine and vehicle pretreated groups again demonstrated a preference for 
the newer conspecific. Again, there was no treatment effect with respect to the amount of 
time the groups explored the novel rat (F (1, 13) = 0.031, p =0.862). Both adult groups 
spent similar amounts of time exploring the newer rat (M = 118.5, SD = 50.39 for 
vehicle, M = 109.8, SD = 40.50 for nicotine) as well as the familiar rat (M = 53.18, SD = 
20.12 for vehicle, M = 41.17, SD = 20.41 for nicotine). Both spent more than 120 
seconds exploring the novel rat and again less than 60 seconds exploring the familiar rat, 
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demonstrating a significant preference for the novel rat for both the vehicle and nicotine 
groups (p < 0.001; Figure 16).  
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 Figure 16. Adult Social Interaction Testing. Orange = adolescent vehicle, Yellow = adolescent nicotine. 
N = 10 per group. Both the adult nicotine and adult nicotine groups performed at similar levels. In the first 
phase of the test, both groups demonstrated a preference for the novel conspecific (p < 0.001). In the 
second phase of the test, again both groups demonstrated a preference for the newest conspecific (p 
<0.001).   
 
d. Sucrose	Preference	Testing	
After 12 hours of water deprivation, rats were placed in a cage with one bottle 
containing a 2% sucrose solution and one bottle containing tap water. After 1 hour of 
exploration and liquid consumption, total liquid changes were calculated. In terms of 
average 2% sucrose solution consumed, the groups did not statistically differ in terms of 
amount consumed (t (18) = 0.608, p = 0.551; Figure 17). Though the adult nicotine groups 
on average consumed less sucrose (M= 13.6, SD = 8.39) and more water (M = 7.7, SD = 
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6.63) than the vehicle controls (M = 16.2, SD = 6.75 for sucrose solution, M = 3.9, SD = 
2.38 for water), there were no significant differences between the two groups (t(18) 
=0.763, p =  0.455, t(18) = 1.705, p =  0.105 respectively; Figure 17). Through the testing, 
the groups consumed similar amounts of liquid, just under 20 mL. The vehicle group 
consumed 16 mL of the 2% sucrose solution and 4 mL of the water, while the nicotine 
group consumed 14 mL of the 2% sucrose solution and 7 mL of the water (Figure 17). 
There was no significant difference in preference for the 2% sucrose solution in the adult 
vehicle and nicotine groups (Figure 17D). The adolescent nicotine group had a 62% 
preference (SD = 33.7) for the sucrose solution as compared to the vehicle group that had 
an 77% preference (SD = 21.94) for the sucrose solution (Figure 17D). Though there 
does appear to be a trend that may suggests the nicotine group has a decrease in 
preference for the sucrose solution, but again it was far from statistically significant (t (18) 
= 1.157, p = 0.263).  
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 Figure 17. Adult Sucrose Preference Testing. In all charts Orange = adult vehicle, Yellow = adult 
nicotine. N = 10 per group. A. The amount of the 2% sucrose solution consumed over the 1-hour test. The 
two groups did not statistically differ from one another. B. The amount of the tap water consumed over the 
1-hour test. The two groups did not statistically differ from one another. C. The total amount of liquid 
consumed over the 1-hour test. The two groups consumed similar amounts of liquid in total through the 
test. D. The preference for the 2% sucrose solution. The two groups did not statistically differ from one 
another. 
 
e. Forced	Swim	Testing	
In forced swim testing, the animal is placed in the tube of water for 15 minutes and 
the behaviours are analyzed. The main behaviours analyzed are time spent swimming, 
time spent climbing the walls and time spent immobile. Over the test, the two groups did 
not statistically differ from one another (Figure 18). The vehicle group spent, on average, 
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447.05 seconds swimming (SD =69.37), while the nicotine group spent 416.91 seconds 
swimming (SD = 68.19; Figure 18). Both groups spent slightly less time immobile than 
swimming and the two groups did not significantly differ from one another in either 
measure (t (18) = 0.586, p = 0.565, t (18) = 0.980, p = 0.340 respectively; Figure 18). The 
adult nicotine group spent 352.89 seconds immobile over the test (SD = 89.92), while the 
vehicle group spent 333.16 seconds immobile (SD = 57.01). Both groups performed 
similarly when the climbing behaviour was analyzed. Both groups spent around 125 
seconds climbing (M = 119.78, SD = 36.49 for vehicle, M = 130.20, SD = 46.43 for 
nicotine). The behaviour of climbing was typical to the beginning of the test as the initial 
behaviour observed. This usually lasted for the first few minutes of the test until the rats 
began the swimming behaviour and exploratory dives.  
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 Figure 18. Adult Forced Swim Testing. Orange = adult vehicle, Yellow = adult nicotine. The amount of 
time over a 15-minute testing period spent swimming, climbing or immobile. The adult vehicle and adult 
nicotine group did not significantly differ on any measure analyzed, including swimming and climbing 
behaviours and time spent immobile. 
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3.22 Cognitive Results  
Cognitive paradigms were all run 31 days after the chronic exposure to nicotine or a 
saline control, at PND 105. There were no pharmacological interventions after the 
adolescent protocol.  
 
a. Object Recognition in Temporal Order 
Object recognition in temporal order takes the requirements from object recognition, 
explained in the adolescent section as well as methods, and adds a second training phase 
with a different pair of objects. Finally, the testing phase consists of one of each of the 
objects previously explored. Adding in the second training phase forces the animal to not 
only remember the first object, but the second as well as integrating that information in 
the testing phase of this task. A two way repeated measures ANOVA doesn’t describe an 
effect of treatment on exploration during the first phase of training (F (1, 16) = 1.114, p = 
0.307). Both the adult nicotine and adult vehicle groups explored both sets of the object 
equally (for the vehicle group: M = 22.18, SD = 8.72, M = 26.21, SD = 10.69; t (9) = 
1.014, p = 0.337, and for the nicotine group: M = 21.72, SD = 10.80, M = 19.2, SD = 
14.56; t (7) = 0.488, p = 0.641), there were no differences between the groups (Figure 
19A). In the second phase of the task, a two way repeated measures ANOVA reveals no 
effect of treatment on exploration (F (1, 16) = 1.788, p = 0.200). The two groups spent 
similar time spent exploring the two identical objects (for the vehicle group: M = 23.72, 
SD = 12.83, M = 24.05, SD = 12.27, and for the nicotine group: M = 23.52, SD = 9.41, M 
= 25.46, SD = 6.10; Figure 19B). A two way repeated measures ANOVA assessing the 
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testing phase again describes no treatment effect on exploration (F (1, 16) = 0.066, p = 
0.800). During the testing phase both adult groups spent more time exploring the object 
from the first phase of training than with the object from the second phase of testing. Post 
hoc tests described a trend towards a preference for the object from the first training 
phase as opposed to the second, though data did not reach significance (p = 0.067 for the 
vehicle group and p = 0.165 for the nicotine group). The adult nicotine and adult vehicle 
groups spent similar amounts of time exploring the object from the second phase of 
testing (M = 10.72, SD = 5.43 for vehicle, M = 8.26, SD = 5.54 for nicotine) as well as 
from the first phase (M = 18.15, SD = 10.94 for vehicle, M = 14.34, SD = 7.89 for 
nicotine; Figure 19C).  In this case it is important to note that the two groups did not 
reliably differ from one another in any of the phases of testing with both groups behaving 
in stereotypic manors.  
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Figure 19. Adult Object Recognition in Temporal Order Testing. Orange = adult vehicle, Yellow= 
adult nicotine, Black = object from first training phase, Grey = object from second phase. A. Training phase 
1 of the task, two identical objects were explored. Bars represent the amount of time spent exploring the 
two identical objects. The vehicle and nicotine group did not differ in their time spent exploring the two 
objects. B. Training phase 2 of the task, two different identical objects were explored. Bars represent the 
amount of time exploring the two identical objects. The vehicle and nicotine group did not differ in their 
time spent exploring the two objects. C-D.  The testing phase of the task represented as the two objects 
(one from the first and one from the second phase of training) and then as the two groups (adult nicotine 
and adult vehicle) to best visualize the differences. The vehicle and nicotine group did not differ in their 
time spent exploring the two objects. 
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4   Discussion  
 
The present series of experiments demonstrates that chronic nicotine during a 
specific critical period of adolescent neurodevelopment can induce an affective disorder-
like phenotype as demonstrated through behavioural, molecular and neuronal analyses. 
These significant changes in behaviour, cellular signaling as well as molecular 
abnormalities are specific to the adolescent period and are not present when rats were 
exposed to nicotine during adulthood.  
Behaviourally, the adolescent nicotine group differed from the vehicle group in 
some measure with each assay run. In the locomotor testing there were no significant 
differences in total distance travelled. Drugs of abuse have previously been described to 
have progressive and long lasting enhancement on locomotor sensitivity with repeated 
exposure (Vaijent et. al, 2010). Acutely, 0.4 mg/kg of nicotine increases basal locomotor 
activity and, like other drugs of abuse, can lead to locomotor sensitization (Zaniewska, 
McCreary & Filip, 2009). In our results, there was no indication of locomotor sensitivity 
nor increased basal activity for neither adolescent nor adult pretreated rats. It is important 
to keep in mind, at the point of testing, there has been a 30-day drug washout period. So, 
at this point there is no effect of the drug on locomotor activity, which could suggest that 
the rats are no longer in a state of withdrawal or dependence on nicotine. While it is 
possible that an increased sensitivity to nicotine would be present during a re-
administration test, at our testing point, it appeared that nicotine did not have a long-term 
effect on basal locomotor activity states. This furthermore suggests that any differences 
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in other behavioural paradigms involving exploration are not merely a function of 
locomotor artifacts, but instead are likely due to selective differences in underlying 
affective, cognitive and/or neuronal and molecular phenotypes induced by nicotine 
exposure.  
 
Adolescent Nicotine Exposure Induces a Persistent Anxiety-Like Behavioural 
Phenotype 
As demonstrated in both open field testing and light dark box testing, there was an 
anxiogenic phenotype found in the adolescent nicotine pretreated rats as compared to 
their vehicle controls. In both tests, adolescent nicotine rats tested at adulthood spent 
significantly less time in the open, more vulnerable areas of each testing apparatus 
(Figures 5 & 6). In these types of tests, rodents tend to avoid the unprotected areas of a 
novel environment, the light/open side and the center portion of the open field (Ohl, 
2003). Rodents, in these novel environments, are conflicted between the drive to explore 
the unknown area and the motivation to avoid potential danger (Ohl, 2003). Nicotine 
pretreated rats spent even less time in these unprotected areas displaying a higher level of 
unconditioned anxiety as compared to the adolescent vehicle pretreated rats. When 
looking at the adult cohort, there were no differences between the groups as both groups 
spent similar amounts of time exploring these unprotected areas, and therefore, displayed 
similar levels of unconditioned anxiety. Altogether, results from the light-dark box and 
open field testing describe a persistent anxiety-like phenotype in the adolescent nicotine 
pretreated rats but not in the adult cohort pretreated with nicotine.  
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Furthermore, in social interaction testing, adolescent rats pretreated with nicotine 
displayed a decrease in exploration of strangers in two different phases of testing. All 
groups (vehicle and nicotine) of adolescent and adult rats, displayed a preference for the 
newest conspecific as compared to an empty cage and more familiar animal (Figure 7 & 
16). Adolescent nicotine pretreated rats, but no other group (adolescent vehicle, adult 
nicotine and adult vehicle) displayed social withdrawal, when it came to exploration of 
the newest conspecific (in both phases). It is important, at this point, to note that there 
were no significant differences in locomotor testing for total movement, nor in object 
recognition for exploration or recognition (Figures 11 & 19). This suggests that the 
differences in exploration of the stranger and novel rats, in the adolescent nicotine group, 
are due to anxiety and social withdrawal as opposed to differences in exploration of novel 
objects or differences in total movement. Again results from both the adolescent and 
adult cohorts describe a persistent anxious and social deficit in the adolescent nicotine 
pretreated rats but not in the adult cohort pretreated with nicotine.  
 As described in the introduction, the most heavily reported long-term effect of 
nicotine exposure is the anxiogenic effects (Dwyer, McQuown & Leslie, 2009; 
Goriounova & Mansvelder, 2012; Slaweki et al., 2003). For example, in 2003, Slaweki 
and colleagues described the anxiogenic effects of adolescent nicotine exposure using 
variations of an open field protocol. Two weeks after 31-36 day old rats were exposed to 
nicotine, rats were tested in two variations of open field testing, in which different aspects 
of exploratory behaviour were analyzed. Results described an anxiogenic effect of 
nicotine on the exploratory behaviour of the rats treated (Slaweki et al., 2003). 
Anecdotally, in humans, smokers use cigarettes to calm down when life stressors make 
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them anxious, suggesting an anti-anxiety property to smoking, while many smokers are 
highly anxious people. Anxiety disorders, and mood disorders like depression have 
strong links to substance abuse problems, including nicotine dependence (Schulz & 
Arora, McCarron et al., 2016; Stein & Sareen, 2015). Supporting the preclinical studies 
as well as the high occurrence of smoking and anxiety disorders, results from this set of 
experiments concurs with the current body of literature linking nicotine-dependence to 
anxiety disorders. Furthermore, we have described a persistent anxiogenic phenotype, 
that lasts longer than the 2 weeks described by Slaweki and colleagues in 2003. Our 
results describe an anxious phenotype after a drug washout period of over a month. 
Furthermore, our results describe this persistent anxiogenic phenotype as being a function 
of developmental period, not just a result of nicotine dependence. 
 
Adolescent Nicotine Exposure Induces Persistent Depressive-Like Symptoms 
Both sucrose preference and forced swim testing can be used to assess two 
symptoms of depressive-like behaviour in an animal model. In both tests adolescent 
nicotine rats displayed depressive-like symptoms, while the adult nicotine group did not 
significantly differ from the control group (Figure 9 & 17). In sucrose preference testing, 
control rats will typically demonstrate a preference for the sucrose solution, especially 
after a period of water deprivation (D’Aquila, Brain & Willner, 1994). This is because 
the sucrose solution is innately more appetitive and rewarding (D’Aquila et al., 1994). In 
these experiments, the adolescent nicotine rats had a significantly decreased preference 
for the 2% sucrose solution as compared to the water (Figure 8). This is proposed to be an 
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indication of anhedonia, an inability to feel pleasure, which is a key symptom in 
depression (Schulz & Arora, 2015). In the adult cohort, there was no statistically 
significant differences between the nicotine and vehicle pretreated groups (Figure 17). 
There seemed to be a trend in the data for the adult cohort that may indicate a level of 
anhedonia as compared to the vehicle group, but, it is first and foremost, not as 
pronounced as the deficit seen in the adolescent cohort, and secondly, not statistically 
significant so cannot be reliably described as a deficit (Figure 17).  
In the forced swim test, one of the most important behaviours to analyze is the 
amount of time spent immobile. This time spent immobile describes a level of resigned 
behaviour in which the animal has given up on swimming and theoretically survival 
(Bogdanova et al., 2013). With the adolescent nicotine pretreated group, there was a 
significant increase in time spent immobile compared to the vehicle control (Figure 9). 
This suggests that the adolescent nicotine group, but not the vehicle group, shows 
persistent depressive-like behaviours. The adult cohort (vehicle and nicotine) spent a 
larger amount of time immobile (more similar to the adolescent nicotine group; Figure 
17). Age and weight play a major factor in behaviour in forced swim testing. The rats 
used in the adult cohort were quite large (close to 1 kg at the time of testing), and 
therefore were much larger than rats used in other studies using forced swim test 
paradigms (Bogdanova et al., 2013). The higher fat content and stabilized ability to float 
could account for the significant differences and increases in time spent immobile 
(Bogdanova et al., 2013). Based on the many articles addressed in this review from 2013, 
comparing results from young adults to much older and larger adults, is inappropriate and 
should not be done. Based on this we can compare the results from each group to their 
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control. With that we see that the adolescent nicotine but not the adult nicotine 
demonstrates persistent depressive symptoms in the forced swim test.  
Our results from the depressive experiments are also in accordance with 
epidemiological studies of adolescent nicotine use. In 2010, Boden and colleagues 
described a causal link between adolescent smoking and the later development of 
depression. The group followed a longitudinal experimental design in which they 
followed adolescents from birth, 1 year and then annually until the age of 16 and then 
three more times at ages 18, 21 and 25 with a battery of questionnaires and assessments 
to analyze their smoking habits as well as their depressive symptoms (Boden, 2010). 
They found that the higher smoking rates were related to greater symptoms of depression.  
Using statistical modelling methods, the group describes a causal link between smoking 
frequency, or nicotine dependence, and major depression (Boden, 2010). Results from the 
analyses presented in this thesis, not only support the causal link found in the human 
model of nicotine dependence and smoking, but further describe this link as being a 
function of developmental period. Similarly, to the findings presented by Boden and 
colleagues (2010), we found that chronic exposure to nicotine during adolescence led to 
persistent depressive symptoms in adulthood, as described through assays performed 
during adulthood, or later on in development. Furthermore, we describe here, that the 
development of depressive symptoms is a function of the developmental period in which 
the animal was exposed to nicotine. When rats were exposed to nicotine during 
adulthood, they did not differ from their vehicle age-matched cohort, while those that 
were exposed to nicotine during adolescence, significantly differed from their age-
matched vehicle counterparts.  
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Adolescent Nicotine Exposure Induces Selective Deficits in Higher Cortical 
Cognitive Tasks 
Depression and anxiety-related disorders have been associated with cognitive 
deficits, particularly with episodic memory and learning, processes that are highly 
dependent of PFC function (Austin, Mitchell & Goodwin, 2001).  In this set of 
experiments, two variations of an object recognition test were used to analyze long-term 
cognitive functions of rats. In the object recognition task, we analyze the ability of the 
animal to distinguish between familiarities of previously encountered objects. In this task, 
it is expected that the rats will spend more time with a novel object, as opposed to a 
familiar object previously encountered (Hannesson et al., 2004). This is a very basic 
memory task that has been linked to hippocampal function (Hannesson et al., 2004). Only 
the adolescent cohort was tested in this task, as following the testing and analysis, no 
deficit was found suggesting there is no cognitive impairment with respect to this task 
following adolescent nicotine exposure. Due to not finding any deficits following the 
adolescent nicotine exposure, the neurodevelopmental period of interest for these studies, 
no adult experiments were performed.  
Next, we used, the object recognition in temporal order task, which is a more 
complex memory task to measure the episodic memory. In this task, rats have to 
discriminate between the order of presented objects . Typically, rats will spend more time 
exploring the object they were first exposed to, which involves the perirhinal cortex as 
well as the medial PFC (Hannesson et. al, 2004). In this task, both the adolescent and 
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adult cohorts were tested. In both the first and second training phases of the task,  all 
groups (vehicle and nicotine) of adolescent and adult rats show similar times  exploring 
the two identical objects, suggesting that there was no preference for one area of the 
testing apparatus or side bias (Figures 11 & 19). In the testing phase of the task, the 
adolescent nicotine pretreated group spent an equal time exploring both the more recent 
and less recent objects. This could be thought of as remembering both objects, but does 
vary from stereotypic behaviour as demonstrated by both the adolescent vehicle group, 
both the nicotine and vehicle group in the adult cohort as well as previous literature 
(Figures 10 & 18, Hannesson et al., 2004). All results considered, again it appears as 
though adolescent, but not adult, chronic nicotine exposure leads to long term changes to 
episodic memory.   
Results from cognitive tasks, are in accordance with the current body literature, 
regarding both preclinical and epidemiological studies. For example, long-term cognitive 
deficits have been observed in rats pretreated during adolescence with nicotine and then 
tested in the 5-choice serial recognition task during adulthood (5-CSRT; Counette et al., 
2009). The 5-CSRT is an operant based task used to study attention and impulse control 
in rodents.  In this task, rats must watch for a light and press the lever associated with 
said light, there are 5 choices for levers to press. First the animal must be trained on the 
paradigm and learn the rules of the task, and then respond correctly to the stimuli. In the 
5-CSRT, authors showed that the rats pretreated with nicotine during adolescence, had 
significantly higher premature responses, as well as a significantly higher proportion of 
incorrect responses to the task when tested in adulthood suggesting impulsivity and 
attentional deficits (Counette et al.,2009). Furthermore, Dwyer, McQuown & Leslie 
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(2009), describe deficits in both spatial and serial recognition tasks in animal models. 
Indeed, these cognitive deficits found following nicotine exposure are not limited to 
preclinical studies of nicotine use. For example, a clinical study supported the association 
between smoking and cognitive problems in young people (Chamberlain et al., 2011). 
Through a battery of neuropsychological tasks, adults between the ages of 18 and 29 
were assessed with groups being split into smokers and non-smokers (Chamerlain et al., 
2011). Authors described the significant cognitive impairments on sustained attention, 
spatial working memory, executive planning as well as risk evaluation. In line with 
results from this clinical study, results from our set of experiments, show persistent 
deficits in executive function following adolescent nicotine exposure. As demonstrated in 
the ORITO task, during integration of information from the two training phases of 
testing, as well as in memory, but in temporal memory as opposed to spatial.  
 
Adolescent Nicotine Exposure Induces a Persistent Hyper-Dopaminergic State in 
the Midbrain Ventral Tegmental Area and Associated Molecular Adaptations in the 
Prefrontal Cortex 
The adolescent cohort was further analyzed at the cellular and molecular levels. 
Using In Vivo electrophysiological recordings, we analyzed baseline firing patterns of 
DA neurons in the VTA (Figure 12). Adolescents chronically exposed to nicotine had, in 
adulthood, a significantly higher VTA DA neuronal activity as well as a significant 
increase in bursting compared to the chronic vehicle group. This suggests that the 
adolescent nicotine group were in a hyperdopaminergic state within the mesolimbic DA 
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pathway that projects from the VTA to multiple areas, including the PFC and NAcc 
(Swanson, 1983). Due to the innervation of the PFC from VTA efferents, the implications 
of both structures (and DA) in depression, in the motivational effects of nicotine, and in 
higher order cognitive tasks, molecular analyses of the PFC were run (Swanson, 1982; 
Laviolette et al., 2008; Schulz & Arora, 2015; Hannesson et al., 2004). To begin the 
molecular analyses, D1 and D2 receptor levels were analyzed in the PFC (Figure 13). Our 
results demonstrate a significant downregulation in PFC D1 but not D2 receptor levels in 
adult rats treated with nicotine during adolescence.  PFC D1 receptors, have been 
implicated in working memory and executive functioning, while PFC D2 stimulation 
does not greatly affect these two functions (Floresco, 2013). Furthermore, D1 receptors 
have been implicated upstream in the de-phosphorylation of ERK, moving ERK from the 
phosphorylated, active, state to the dephosphorylated, inactive, state (Girault et al., 2007). 
This function of D1 receptors makes sense as there is not only a downregulation in D1 
receptors, but also a large increase in phosphorylated ERK1/2 levels (Figure 13). 
Interestingly, we found changes in PFC phosphorylated ERK1/2 levels, but not  in total 
ERK1/2 levels in adult rats treated with nicotine during adolescence. This suggests that 
there is not a deficit in the production or elimination of ERK1/2, only in the de-
phosphorylation state. The ERK signaling pathway has previously been implicated in 
addiction, and is involved in many different cell functions, including cell growth and 
differentiation as well as neuronal plasticity (Girault et al., 2007). Therefore, a large 
upregulation in ERK1/2 function could potentially have vast effects on PFC functioning 
and efficiency. Bruchas and Chavkin (2010), previously described the role of ERK, 
through the kappa opioid receptor system, in the stress-induced responses including both 
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anxiety and depression. In contrast, CaMKII is an effector protein that is implicated in 
long-term potentiation of a synapse and ultimately activated through NMDA-type 
glutamate receptors, which allow an influx of Ca 2+ (Shifman et al., 2006). In our results 
there were no significant changes in CaMKII levels in the adult PFC of adolescent 
nicotine pretreated rats, lending to the idea that there is a disturbance in the DA system 
following chronic adolescent nicotine that leads to changes in the DA-D1-ERK receptor 
linked pathways, but not in the DA-D2-CaMKII related signaling pathway. Based on its 
role in cell proliferation, it’s not surprising that CaMKII has also been implicated in 
mood and anxiety disorders. In 2004, Du and colleagues described the role of CaMKII in 
depression and anxiety disorders through modification by serotonin reuptake inhibitors 
(SSRIs). The group describes the increased auto-phosphorylation and therefore activity of 
CaMKII in the hippocampus following treatment with selective serotonin reuptake 
inhibitors (SSRIs; Du et al., 2004). It is important to note that SSRIs are commonly 
prescribed on their own or in conjunction with therapy in the treatment of both depression 
as well as anxiety disorders. Furthermore, both pathways have been previously 
implicated in reward processing/reward memory following exposure to drugs of abuse, 
such as opioids and nicotine (Lyons et al., 2013; Rosen et al., 2016). Both molecular 
pathways analyzed, have been previously associated with the affective disorders 
described in behavioural experiments, though only the D1-ERK1/2 pathway was 
implicated in our experiments, within the PFC.  
All results considered together describes a depressive, anxious phenotype with 
corresponding social and cognitive deficits. Considering depression in a general sense, it 
is commonly diagnosed as co-morbid with anxiety disorders, substance abuse problems 
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as well as with compulsive control disorders (Schulz & Arora, 2015). Furthermore, 
symptoms include anhedonia, suicidal thoughts, feelings of worthlessness (in animal 
models can be thought of as resigned behaviours in FST), impairments in social 
functioning and integration cognitive deficits (McCarron et al., 2016; Hannesson et al., 
2004). Neuroanatomically, associations have been made between the PFC, cingulate 
cortex, hippocampus and striatum (Schulz & Arora, 2015).  In our results, behaviours 
describe a good portion of symptoms described in the DSM-5 for diagnosis of depression 
in humans. Ultimately, the present results demonstrated that in adolescent rats chronically 
exposed to nicotine, a persistent depressive and anxiety-like phenotype takes place that is 
present at least until adulthood. These same long term changes were not found when an 
adult cohort was chronically exposed to nicotine and tested following the same latency 
between exposure and testing. Results from our adult cohort lends to the conclusion that 
the deficits and changes found in our adolescent cohort are a function of being exposed to 
nicotine during a critical and plastic period of development and not a function of chronic 
nicotine exposure itself. Furthermore, these results are supported by significant molecular 
and cellular changes in the adolescent nicotine cohort. A month following the chronic 
nicotine protocol, adolescent rats were found to have persistent changes in DA cell 
activity and resulting D1 receptor and ERK1/2 concentrations.  
Chronic nicotine-dependence is maintained through the dopaminergic pathway 
(Laviolette & Van Der Kooy, 2004). Nicotine, in chronic dependence, results in an 
increase in DA transmission through the mesolimbic pathway (Laviolette & Van Der 
Kooy, 2004). Results from In Vivo electrophysiology during adulthood demonstrate that 
this increase in DA release in the mesolimbic pathway persists into adulthood. This 
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persistent increase in DA release, resulted in a downregulation in D1 receptors on the 
postsynaptic membrane, which then downstream lead to an upregulation in the 
phosphorylated form of ERK1/2 in the PFC. The change in dopamine transmission, 
described through both In vivo electrophysiology as well as western blots, underlies the 
depression and anxiety phenotype.  Major depressive disorder is associated with 
diminished dopaminergic neurotransmission by way of diminished DA release or 
impaired signal transduction (Dunlop & Nemeroff, 2007). Similarly, DA polymorphisms 
have been implicated in anxiety disorders, describing a deficit in transmission of DA 
(Gallagher & Schrag, 2011). In our experiments the anxious and depressive phenotype 
was due to the impaired signal transduction from the downregulation of D1 receptors. 
Furthermore, we know from previous studies described, that phosphorylated ERK1/2 is 
also implicated in depression and anxiety disorders, a result that is supported by this 
study. Finally, the mesolimbic pathway is important in learning and memory, along with 
ERK and CaMKII. Dysregulation and disruption to this pathway, as we found with our 
experiments, resulted in cognitive deficits in higher order cognitive tasks.  
 
Future Directions 
Based on results from this set of experiments, further cellular and molecular 
analyses should be performed on other structures of interest, such as the BLA, vHipp, 
NAcc and PFC. Based on results from the molecular analyses in this study, with the PFC. 
Further cellular analyses using In Vivo electrophysiological recordings could further 
describe the role and relationship of the PFC in the vast changes that take place following 
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adolescent nicotine exposure. Furthermore, other areas of interest could be the vHipp, 
because of its’ role in memory and our deficits found in object recognition in temporal 
order, the NAcc, because of its’ role in the mesolimbic pathway and reward processing, 
as well as the BLA due to its’ role in emotional regulation, processing and memory. 
Assessing molecular changes, with respect to the up and downregulation of key 
molecules in cellular process pathways, as well as changes in baseline firing in these 
structures, could further lend to what long term changes underlie the significant 
behavioural changes described in this thesis. Furthermore, pharmacological reversals 
should be attempted to further understand and begin treatment options for those suffering 
from nicotine addiction, and the associated deficits that have resulted from adolescent 
nicotine use. A start for pharmacological reversals would be micro-infusions of ERK1/2 
inhibitor into the PFC. Based on results described in this thesis, we would expect that 
blocking ERK1/2 in the PFC of a nicotine pretreated animal would lead to a reversal of 
behavioural deficits. Based on the role of ERK1/2 in anxiety and mood disorders, we 
would expect a reversal of the anxiety and depressive symptoms. Furthermore, we would 
expect a reversal in the cognitive deficits found in ORITO, as ERK1/2 is involved in 
neuronal plasticity and the PFC is important in integration of information.  
Limitations of the Current Studies 
 A clear limitation to this work is the difficulty of describing depression, a highly 
complex mood disorder, in an animal model because of the difficulty describing a feeling 
or mood in an animal model. By using a combination of behavioural, cognitive, In Vivo 
electrophysiology and western blot techniques, that characterize different aspects of the 
depression, we have attempted to best describe the model as a depressed-phenotype to 
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meet the diagnosis criteria set by the DSM-5. Though there is still much criticism on 
animal models of depression, as some of the core features of depression may be ‘un-
modellable’ in an animal model (Matthews et al., 2005). 
 Another limitation to our study is the method in which the rats received the 
nicotine. The nicotine was injected subcutaneously into the animal, as opposed to a self-
administration paradigm. This means that the rats were stressed when infused with the 
nicotine solution as opposed to administering it themselves. Furthermore, this limits our 
knowledge as to whether or not the animal was addicted to nicotine or if nicotine acted as 
a stressor to the animal.  
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